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IMPACT OF PARENTAL DEPRESSION ON PHARMACOTHERAPY AND 
PSYCHOTHERAPY AMONGST CHILDREN AND ADOLESCENTS 
WITH DEPRESSION DIAGNOSES 
YIYANG YUAN 
 
ABSTRACT 
Objective 
Parental depression is considered amongst the greatest risk factors for the diagnosis of 
depression in children and adolescents. Less is known about how and to what extent 
parental depression influences their depressed children’s depression treatment. Building 
on Bronfenbrenner’s ecological model and Andersen’s model, this study aimed to assess 
the impact of parental depression on depressed children and adolescents’ depression 
treatment.  
Data/study population 
Children and adolescents aged 3 to 17 diagnosed with depression in MarketScan Claims 
and Encounters Database (2010–2014) 
Method 
Psychotherapy, pharmacotherapy, and combination treatment were examined. Study 
covariates were described. Chi-square tests with Bonferroni correction were conducted to 
examine the difference in study covariates between types of depression treatment. 
Generalized estimating equation models were used to examine the effect of parental 
depression on the likelihood of receiving depression treatment, controlling for study 
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covariates, while accounting for the clustering of children and adolescents in the same 
household.  
Result  
Children and adolescents with depressive parents were less likely to use psychotherapy 
(aOR: 0.80, 95% CI: (0.74, 0.86)), and more likely to use antidepressant (aOR: 1.41, 95% 
CI: (1.28, 1.56)) and combination treatment (aOR: 1.55, 95%CI: (1.43, 1.68)), compared 
to those without. Depressed children and adolescents living with depressed siblings in the 
same family were significantly less likely to use any depression treatment (aOR: 0.47, 
95% CI: (0.41, 0.55)).  
Conclusion  
The significant relationship between parental depression and their depressed children and 
adolescents’ treatment indicates that consideration should be given to parents’ decision-
making and engagement in the treatment. 
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 INTRODUCTION 
1. Background 
Depression is amongst one of the most common mental disorders affecting the 
children and adolescents in the United States. Over the years, a number of population 
surveys have documented the prevalence and severity of depression in children and 
adolescents. The National Survey of Children’s Health (NSCH 2011/12) documented a 
prevalence of 2.2% of those 2 to 17 years of age currently having depression, which 
represented 1.4 million children and adolescents in the U.S. About half of these children 
and adolescents were rated for their condition by the parent or caregiver as moderate or 
severe.1 Recent data collected through the National Survey on Drug Use and Health 
(NSDUH) estimated that in 2015, for U.S. adolescents aged 12 to 17, 12.5% had suffered 
at least one major depressive disorder episode in the past 12 month,2 and 8.8% had 
experienced in the past year a major depressive disorder with severe impairments that limit 
or jeopardize the individual’s involvement with their daily activities.3  
Early screening and timely treatment for depression in children and adolescents are 
particularly crucial, because they can help reduce recurrence and/or persistence of the 
disorder into adulthood.4 Usual treatment for child and adolescent depression consists of 
psychotherapy, pharmacotherapy, and combination treatment.5 Psychotherapy is 
recommended by the American Psychiatric Association (APA) and the American Academy 
of Child and Adolescent Psychiatry (AACAP) as the essential component of treatment for 
children and adolescents with depression. Proven effective against childhood and 
adolescent depression,5,6 cognitive behavioral therapy (CBT) usually involves behavioral 
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activation techniques, along with methods to improve coping, communication and 
problem-solving skills, to regulate emotions and to combat negative patterns of thinking.5 
CBT has moderate effects on reducing depressive symptoms, but limited evidence exists 
to demonstrate if CBT will be effective in treating acute depression disorder in 
adolescents.5 
Adjuvant pharmacotherapy with antidepressants is considered appropriate at times. 
In prescribing antidepressants for depressed children and adolescents, it is strongly 
recommended that the severity and history of depression be taken into account with careful 
clinical monitoring and follow-up.5,7 As of now, only fluoxetine (proprietary name: Prozac), 
an SSRI, has been approved by the U.S. Food and Drug Administration (FDA) for 
treatment of depression in pediatric patients over 8 years of age, and is regarded as the first-
line pharmacotherapy for child and adolescent depression.7,8 Escitalopram (proprietary 
name: Lexapro), also belonging to the SSRI class, is approved by the FDA to treat major 
depressive disorders in adolescents aged 12 and above.5,9 There is limited consistent 
evidence from clinical trials that support the effectiveness of other antidepressant agents in 
decreasing depression for children and adolescents. More data is needed to demonstrate the 
efficacy of antidepressants that are licensed for adult patients on depression in children and 
adolescents. Irrespectively, the effectiveness of pharmacotherapy in treating depression in 
the young is not really clear.10 
The APA and AACAP recommend combination treatment in pediatric patients with 
moderate to severe depression.5 Results from the Treatment for Adolescents with 
Depression Study (TADS) indicated that the combination of CBT and fluoxetine was the 
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most effective treatment for attaining remission of adolescent depression11,12 and offered 
the most favorable risk-benefit profile over CBT or fluoxetine alone.13,14 A recent Cochrane 
meta-analysis of 11 randomized clinical trials, nonetheless, found limited evidence to 
conclude the relative effectiveness of psychotherapy, pharmacotherapy and the 
combination of both in treating childhood and adolescent depression.15  
Even with the treatment options available, many children and adolescents with 
depression remain undertreated.5,9,16,17 Children and adolescents with the most severe and 
persistent symptoms, and therefore in most need of mental health services, were not 
necessarily the ones that actually received services.4 Using recent data from a nationally 
representative medical claims database, Soria-Saucedo et al. reported that less than 60% of 
the depressed children and adolescents aged 6 to 17 years of age received treatment for 
depression. More specifically, 33.6% received psychotherapy only, 24.8% received 
antidepressant medication only, and merely 2.7% had received the combination therapies.9 
Without proper treatment, depression in the young may persist into adulthood, affecting 
one’s physical and mental well-being as well as their quality of life.10 Hence, it is crucial 
to explore and examine the factors that may be involved in utilization of treatment for 
depression. 
The role of parents in families with depressed children and adolescents is salient as 
it relates to their service utilization. Most children and adolescents need to rely on their 
parents for caregiving as well as social and financial support to navigate through the 
healthcare system. But what are the consequences if their parents also suffer from 
depression?  
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According to national studies, it is not uncommon for U.S. parents to be diagnosed 
with depression sometime during their lives. Findings from National Health Interview 
Survey (NHIS 2013) indicated that 5% of U.S. parents in two-parent households and 11% 
of single parents had two or more symptoms pertaining to depression.18 National 
Comorbidity Survey Replication (NCS-R 2002) estimated that 17.3% of parents with at 
least one child had ever experienced major or severe depression in their lifetime.19 Mothers 
were more prone to the disorder, as about 21.3% of the mothers, a proportion nearly twice 
that of fathers (12.6%), had suffered from major or severe depression sometime during 
their lives. Prevalence of lifetime major depressive disorders in parents increased by the 
ages of their children, with the lowest in parents having children under 5 years of age 
(14.8%) and highest in parents having children between 13 and 18 years of age (19.3%). 
The same survey estimated that 7.2% of U.S. parents had suffered from major or severe 
depression in the past 12 months, regardless of the age of the child.19 Data from National 
Epidemiologic Survey of Alcohol and Related Conditions (NESARC 2001/02) had similar 
estimates.20  
Parental depression is considered as one of the greatest risk factors for child 
behavioral and mental health disorders, including depression.19,21–23 It still remains a 
challenge to delineate whether this association could be attributed to parental depression 
and other relevant environmental risk factors, or a genetic predisposition.24 Nonetheless, 
depressed parents show impairments in parental functioning20 and display negative 
parenting styles, including less child monitoring,25,26 fewer supportive behaviors,19 and 
harsh discipline,26 which may lead to a chronically stressful family environment and 
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subsequently contribute to the development of their children’s mental health problems.19,23 
A series of studies have consistently reported that children with parents suffering from 
depression, compared to those without, face elevated risk of developing depression either 
during childhood or in early adulthood.24,27 
For children and adolescents living with depressed parents who later developed 
depression themselves, little is known about how and to what extent their parents’ 
depression would impact their utilization of treatment for depression. Parents’ perception 
of depression may be influenced by their own experiences with the disorder,28 which may 
further influence how they would engage their depressed children and adolescents in 
depression care. Research found that mothers with depressive disorders had higher odds of 
reporting their children’s behaviors negatively, compared to outside evaluators,29,30 and 
that after being treated for depression, their ratings of children’s behaviors significantly 
improved.31 In another study, Zimmerman et al. distinguished between previous experience 
with depressive symptoms and formal depression diagnosis in mothers, where only the 
former had significant association with children’s mental health service use. They 
suggested that parents’ sensitivity with the burden of mental health illness played a more 
important role in ensuring their children received proper treatment.32  
Early intervention and treatment for depression in adolescents and younger children 
is essential to reduce the rate of depression and improve their physical and mental well-
being. It is critical to evaluate the factors that may play a role in depressed children and 
adolescents’ use of treatment in order to design targeted interventions and improve the care. 
As depression in parents affects parent-child interaction and quality of parenting, it is 
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worthwhile to examine whether and how parental depression would be associated with 
their children and adolescents’ depression treatment. Findings from this study could have 
future implications for depression treatment in children and adolescents with a family focus 
and from a health services research perspective. 
2. Conceptual framework  
The conceptual framework of this study was built on the Bronfenbrenner’s 
ecological model33 and Andersen’s model for healthcare utilization.34 Bronfenbrenner’s 
ecological model was chosen because it recognized the multilevel influences on health 
from individual, interpersonal, institutional, and societal factors, as well as the dynamic 
interactions amongst these factors. (Figure 1) Andersen’s model was chosen because it was 
the classic model that reflected how predisposing, enabling and need factors would impact 
healthcare utilization. (Figure 2) A conceptual framework combining these two models 
delineated the role of and the inter-correlations between the factors that were assessed in 
this thesis.  
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Figure 1. Conceptual framework of the study: adapted from Bronfenbrenner’s 
ecological model33 
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Note: Factors on individual-, interpersonal-, institutional- and societal-level from Bronfenbrenner’s ecological model (in circles) have been 
integrated with the Andersen’s model. 
Figure 2. Conceptual framework of the study: adapted from the Andersen’s model34
INTERPERSONAL 
Parental depression 
Number of depressed 
children in the family 
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Individual level factors, such as sociodemographic factors including children and 
adolescents’ age and gender (predisposing factors), and clinical characteristics including 
mental health comorbidities (need factor) could impact their health conditions as well as 
use of mental health services.35  
(1) Age of the child/adolescent: Studies have shown that older adolescents were 
less likely to receive mental health services compared to younger adolescents.4 
(2) Gender of the child/adolescent: Previous research based on nationally 
representative surveys documented gender disparities in depression treatment, 
although the findings were somewhat inconsistent with regards to the specific 
types of treatment being assessed, and due to differences in study design, 
sampling strategy and analysis models. Teenage girls aged 13 to 18 were 
significantly more likely to use antidepressants than boys of the same age 
group.36 In a different study, girls aged 7 to 14 were less likely to receive 
depression treatment, compared to boys in that same group.32  
(3) Mental health comorbidity of the child/adolescent: Children and adolescents of 
parents suffering from depression have been shown to be at an elevated risk of 
developing depression as well as other internalizing and externalizing 
behavioral problems.19,37 For individuals with depression, mental health 
comorbidities have been established as a proxy of illness complexity,38 which 
is associated with utilization of mental health services.  
Interpersonal influences, in particular the interactions within the family, play a 
central role in children’s health and utilization of appropriate health services. Parental 
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depression, as one interpersonal factor, is implicated at all levels (predisposing, enabling 
and need), and is the focus of this study.  
(1) Parental depression: Caregivers’ ability to recognize children’s mental health 
problems39,40 (need factors) and knowledge of and attitude towards treatment35 
(predisposing factors) are associated with mental health service utilization for 
adolescents and children. In the context of this study, parental depression has 
an impact on how parents perceive their children’s behaviors29,30 and the 
severity of their children’s mental health conditions. In addition, parents’ 
personal use of mental health services may add to their awareness of the 
disorder and knowledge of treatment available, and therefore facilitate their 
children and adolescents’ involvement in proper care (enabling factors). 
Parental depression was shown in a few studies to be associated with increase 
in children’s overall mental health service utilization,23,41 but such finding were 
not consistent.35  
(2) Number of depressed children/adolescents in the family: Number of depressed 
children in the household may influence the family dynamic and contribute to 
the family burden that have been shown to influence children’s use of mental 
health services.42 
On the institutional level, the health system in terms of insurance structures and 
healthcare providers as enabling factors could have a significant impact on children’s 
health and use of health services.43 
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(1) Health insurance plan: The architecture of the insurance plans might relate to 
the extent of initial diagnosis being made and type of treatment among 
depressed patients. The use of medication treatment, psychotherapy or a 
combination of the two might be tied to the insurance arrangement. By design, 
Health Maintenance Organization (HMO) plans offer less flexibility in terms of 
capitated payment arrangements and options of specialists than Preferred 
Provider Organization (PPO) plans. Providers may be more likely to prescribe 
recommended treatment and prescriptions according to the use of formularies 
and/or protocols in more restrictive insurance arrangements such as HMO.9,44  
On the other hand, cost of treatment is one of the most critical barriers to care. 
As cost of services in the U.S. is closely related to insurance coverage, payment 
structure of insurance plans might also impact patients’ use of services.45 
Consumer-Driven Health Plans (CDHP) and High-Deductible Health Plans 
(HDHP) are two popular variants from PPO plans. They usually share the same 
network as PPO plans with a lower premium and higher deductible. Previous 
research indicates that compared to those in PPOs, enrollees in such high-
deductible plans are more likely to forgo care due to concerns of cost.46 Higher 
deductible levels are also shown to be associated with discontinuation in 
antidepressant medications.47 There is little empirical evidence on how 
CDHP/HDHP, compared to PPO, would impact depressed children and 
adolescent’ use of depression treatment.  
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(2) Healthcare providers: Soria-Saucedo et al. found mental health specialists were 
8.6 times more likely to prescribe the recommended combination of 
psychotherapy and pharmacotherapy, suggesting impact on children’s receipt 
and engagement in care from providers. Parental depression may correlate with 
these institutional level factors, in terms of choice of private insurance plans 
and communication with the providers.  
Last, societal factors refer to macro-level influences on children’s mental health 
wellbeing and use of mental health services.  
(1) Regional difference: This study will briefly assess the study outcomes with 
regards to U.S. regional differences (Northeast, Midwest, South, and West). 
Geographic disparities in mental health care for children have been observed.48 
Merikangas et al. reports that antidepressant medication use in depressed 
adolescents were highest in the Midwest (15.9%) and lowest in the South 
(8.8%), but there are no statistically significant differences among the four 
regions.36
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 RESEARCH OBJECTIVE 
The objective of this study is to examine the impact of parental depression along 
with individual-, interpersonal-, institutional- and societal-factors on depressed children 
and adolescents’ use of depression treatment.  
1. Research questions 
This study aims to answer the following two research questions: 
(1) Primary question: To what extent parental depression impacts their depressed children 
and adolescents’ use of anti-depressant treatments, and  
(2) Secondary question: To what extent individual (age, gender, and comorbidity), 
interpersonal (number of depressed children and adolescents in the family), 
institutional (private insurance plans and healthcare providers), and societal (region) 
factors impact children and adolescents’ anti-depressant treatment. 
2. Hypotheses 
On the basis of the primary research question, this thesis proposes the following 
hypotheses: 
Hypothesis 1: Depressed children and adolescents with a parent also diagnosed with 
depression will be more likely to receive psychotherapy, pharmacotherapy or combination 
treatment for their initial diagnosis of depression, than those without a parent with a 
diagnosis of depression.  
Hypothesis 2: Depressed children and adolescents with a parent also diagnosed with 
depression will be more likely to receive psychotherapy, than those without a parent with 
a diagnosis of depression.  
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Hypothesis 3: Depressed children and adolescents with a parent also diagnosed with 
depression will be more likely to receive pharmacotherapy, than those without a parent 
with a diagnosis of depression.  
Hypothesis 4: Depressed children and adolescents with a parent also diagnosed with 
depression will be more likely to receive combination treatment, than those without a 
parent with a diagnosis of depression.  
 15 
 METHODOLOGY 
1. Data 
IBM Watson/Truven AnalyticsSM MarketScan Commercial Claims and Encounters 
database (2010 to 2014, “claims database”) was the primary database for this study. The 
claims database represents medical experiences from approximately 50 million people and 
their dependents covered by employer-sponsored health insurance.49 For the purpose of 
this study, annual outpatient services and drug claims data were used.  
2. Study population  
2.1. Inclusion/Exclusion criteria 
As shown in the flow chart (Figure 3), children and adolescents with diagnoses of 
bipolar disorder (ICD-9: 296.0x, 296.4x), schizophrenia (ICD-9: 295.6), or mixed mental 
disorders (depression and psychosis, depression and bipolar disorder) were first excluded 
from the study, because children and adolescents with these diagnoses may receive 
prescriptions that overlap with the ones prescribed to treat depression.50  
 Children and adolescents aged 3 to 17 at the first appearance of a claim in the 
claims database were included in the study if they met the following criteria:  
(1) two or more outpatient diagnoses of depression, and 
(2) no diagnoses of depression for at least 180 days prior to the first diagnosis listed 
in (1), and 
(3) were noted as the “child” in terms of the relationship to the primary beneficiary 
of the insurance plan, and 
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(4) remained covered in a given health insurance plan (Preferred Provider 
Organization (PPO), Health Maintenance Organization (HMO), Consumer-
Driven Health Plans (CDHP), or High-Deductible Health Plans (HDHP)) for at 
least 12 continuous months following the diagnosis. 
In particular, as parental depression was a main covariate in this study, parents were 
identified through having the same de-identified family index and documented as the 
primary beneficiary of the insurance plans as either “employee” or “spouse”. If the primary 
beneficiaries of the insurance plans did not generate any claims occurring during the study 
period, i.e., only their children or adolescents had medical claims, but not themselves, there 
was no other means available to identify parents. Children and adolescents would be 
excluded if their parents could not be identified in the database. They would also be 
excluded if they had any missing information on the study covariates.  
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Figure 3. Study population inclusion/exclusion criteria 
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2.2. Depression diagnosis and relevant comorbidity  
Depression diagnosis was identified by the combination of the procedure code 
(Current Procedural Terminology, “CPT”) and the diagnosis code (International Statistical 
Classification of Diseases, 9th version, “ICD-9”). Specifically for this study, the CPT codes 
for the psychiatric diagnostic procedure were “90801” and “90802” in years prior to 2013, 
and “90791” and “90792” in 2013 and after;51 ICD-9 codes for depression diagnoses 
include “296.2x”, “296.3x”, “298.0”, “300.4”, “309.0”, “309.1”, “309.28”, and “311”. An 
outpatient medical claim was defined as a depression diagnosis claim if it contains any 
combination of the procedure and diagnosis codes above. As evaluated in a number of 
previous studies and demonstrated good positive predictive value,9,52 children and 
adolescents to be included had at least two claims of depression diagnosis.  
Psychiatric comorbidities have been shown as a proxy for the complexity of 
depression.9 Following a similar method, the following psychiatric comorbidities, if 
occurring within 12 months following the initial depression diagnoses, were included and 
examined in this study: attention-deficit hyperactivity disorder (ADHD, ICD-9: 314.00, 
314.01), anxiety disorder (ICD-9: 300.0), post-traumatic distress disorder (PTSD, ICD-9: 
309.81), and suicidal ideation (ICD-9: V62.84). 
3. Variables  
3.1. Outcome variable  
The outcome of this study is whether the patient had used any treatment for 
depression, in addition to specific types of treatment. Three types of depression treatment 
are considered: (1) “Psychotherapy”, only psychotherapy was prescribed, (2) 
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“Pharmacotherapy”, only antidepressant medication was prescribed, and (3) “Combination 
treatment”, a combination of both psychotherapy and pharmacotherapy was prescribed. 
Only treatment prescribed following the initial diagnosis was assessed. Any change in the 
treatment regimen over time was not the focus of this current study and therefore not 
examined.  
(1) Psychotherapy  
Psychotherapy was identified based on the procedures that occurred and 
documented by CPT codes.9,51 This study examined individual, interactive 
individual, family, group and interactive group psychotherapy. Specific CPT 
codes for these psychotherapies were listed in Appendix Table A.1.  
(2) Pharmacotherapy 
Pharmacotherapy for depression, including first-line, second-line and non-
evidence-based antidepressant medications,9 was determined by outpatient 
prescription drug claims based on national drug codes. The detailed list of 
national drug codes were obtained by manually searching the FDA National 
Drug Code Directory by the proprietary names and active ingredients of 
antidepressant medications indicated in previous literature.9,53 (Appendix Table 
A.2) 
(3) Combination treatment 
Combination treatment was defined as the use of any psychotherapy plus any 
antidepressant medications following the initial depression diagnosis, 
regardless of the type or duration of the psychotherapy and pharmacotherapy.  
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3.2. Primary covariate  
Parental depression was defined in a dichotomized (yes/no) fashion. If a parent had 
a diagnosis of depression (ICD-9: 296.2, 296.3, 298.0, 300.4, 309.0, 309.1, 309.28, 311), 
or had received any antidepressant medication (Appendix Table A.2) during the study 
period, the parent would be regarded as having depression. 
3.3. Other covariates 
Following the conceptual framework, the following covariates were examined:  
(1) Individual factors  
Individual factors include children and adolescents’ age at the first appearance 
of the claim in the database (early childhood: 3–5 years; childhood: 6–11 years; 
adolescent: 12–17 years), gender (male and female), and comorbidities (ADHD, 
anxiety disorder, PTSD, and suicidal ideation). 
(2) Interpersonal factor 
In addition to parental depression, the study also examined another 
interpersonal factor, number of children and adolescents diagnosed with 
depression in the household. This covariate had two levels, one depressed 
child/adolescent only and more than one depressed child/adolescent.  
(3) Institutional factors 
For employer-sponsored health plans, the analyses focused on the following: 
Preferred Provider Organizations (PPO), Health Maintenance Organizations 
(HMO), Consumer-Driven Health Plans (CDHP), and High-Deductible Health 
Plans (HDHP). Compared to PPO plans, HMO plans are less flexible in the 
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options of specialists, and are paid on a capitated basis. In addition, CDHP and 
HDHP generally share the same network as PPO plans with lower premiums 
yet with higher deductibles. 
Prescriber of the depression treatment was also assessed. Prescribers were 
categorized into three categories: (1) primary care providers, including primary 
care doctors, general internists, family physicians, pediatricians, and nurse 
practitioners, (2) mental health specialists, including psychiatrists, child 
psychiatrists, psychologist, psychiatric nurse, and therapists, and (3) other, if 
the prescriber information was missing or did not fall into either of the two 
previous categories. Examples of the “other” providers include prescription 
obtained from acute care hospitals without physician specified, multispecialty 
physician group, public health agency, etc.  
(4) Societal factor  
The 4 U.S. geographic regions (Northeast, South, Midwest, and West) that 
depressed children and adolescents’ primarily resided in were included in the 
study. 
4. Statistical Analysis 
Parental depression status, followed by individual (age, gender, comorbidity), 
interpersonal (number of depressed children and adolescents in the household), 
institutional (health insurance and provider type) and societal factors (U.S. geographic 
region) were presented in descriptive statistics for the entire study population and then by 
the treatment prescribed (psychotherapy only, pharmacotherapy only, a combination of 
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both, and no treatment at all). Chi-square tests were conducted to examine the differences 
in the distribution of each study covariate between types of depression treatment. P-values 
of these statistical tests were adjusted with Bonferroni correction to reduce the potential of 
type I errors resulting from multiple comparisons.  
Multivariate logistic regression was used to examine the effects of parental 
depression on the likelihood of receiving any depression treatment and each of the three 
types of treatment, controlling for the other study covariates. Interactions were examined 
between study covariates and ruled out if they were not statistically significant or not policy 
relevant. The interaction term between types of provider and health insurance plans was 
selected in the models in addition to their main effects. C statistics and Hosmer-Lemeshow 
goodness-of-fit tests were used to support the performance of the models. 
Further, although the unit of the analysis was individual child or adolescent, given 
that a family might have more than one child and/or adolescents diagnosed with depression, 
generalized estimating equations (GEE) were incorporated into the models to account for 
clustering of children and/or adolescents in the same households.  
The Boston University Institutional Review Board approved this study and 
considered this de-identified data and was deemed non-human subject research. All 
statistical analysis was conducted in SAS 9.4.  
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 RESULT 
1. Overview of the study sample 
A total of 35,180 children and adolescents met the inclusion criteria and were 
included in the study. As shown in Table 1, the majority of them were teenagers, with close 
to 70% aged 12 to 17 years. Gender disparity was observed, with 63.47% of the study 
sample being females, and only 36.53% being males. A total of 8,646 children and 
adolescents had one or more types of mental health comorbidities within 12 months of their 
depression diagnosis, representing nearly a quarter of the study sample. The most common 
comorbidity was anxiety disorders (14.00%), followed by ADHD (10.33%), PTSD 
(1.59%), and lastly, suicidal ideation (1.43%). (Table 1) 
In terms of parental depression, 42.46% of the children and adolescents included in 
the study had parent(s) diagnosed with depression. (Table 1) Over 96% of the study sample 
were the only depressive child or adolescent in the family.  
PPO appeared to be the most popular type of health insurance plan, with nearly 70% 
of the study sample enrolled in such a plan. 18.18% were enrolled in HMO, followed by 
7.47% in a CDHP plan, and 4.80% in a HDHP plan. (Table 1) Over 3 quarters of the sample 
(78.61%) obtained their treatment prescription from mental health providers. 
Approximately 10% depressed children and adolescents were seen by primary care 
providers.  
With regards to geographic region, 30.63% came from the Midwest, 28.29% from 
the South, 20.92% from the West, and 20.17% from the Northeast. 
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Table 1. Demographic characteristics of the study sample (N = 35,180) 
   
N % 
Parental depression   
 No  20,243 57.54 
 Yes  14,937 42.46 
Number of depressed children in the family   
 1 child  33,794 96.06 
 More than 1 child 1,386 3.94 
Age group 
   
 
3 to 5 years 1,019 2.90  
6 to 11 years 9,739 27.68  
12 to 14 years 15,517 44.11  
15 to 17 years 8,905 25.31 
Gender 
   
 
Male 
 
12,851 36.53  
Female 
 
22,329 63.47 
Comorbidity   
 ADHD 3,634 10.33 
 Anxiety disorders 4,924 14.00 
 PTSD 558 1.59 
 Suicide ideation 502 1.43 
Insurance plan 
  
 
PPO 
 
24,471 69.56  
HMO 
 
6,394 18.18  
CDHP 
 
2,628 7.47  
HDHP 
 
1,687 4.80 
Provider type 
  
 
Mental health providers 27,654 78.61  
Primary care providers 3,512 9.98  
Other providers 4,014 11.41 
Region 
   
 
Northeast 7,095 20.17  
Midwest 10,774 30.63  
South 
 
9,951 28.29  
West  
 
7,360 20.92 
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2. Types of depression treatment 
As presented in Table 2, the majority of the study population who received some 
forms of depression treatment: 43.12% of the study population received only 
psychotherapy after their initial depression diagnosis, and 36.65% received both 
psychotherapy and antidepressant medications. In contrast, pharmacotherapy treatment 
was much less prevalent, with only a little over 10%.  
 
Table 2. Treatment prescribed following the depression diagnoses (N = 35,180) 
 
N % 
Psychotherapy only 15,168 43.12 
Antidepressant medication only 3,692 10.49 
Psychotherapy and antidepressant 
medication 
12,893 36.65 
No treatment prescribed 3,427 9.74 
 
3. Bivariate analysis 
Bivariate analysis with a chi-square test assessing the association between each of 
the study covariates and depression treatment are presented in Tables 3 and 4.  
3.1. Interpersonal factors - Parental depression, number of 
depressed children in the family and depression treatment  
Use of depression treatment in their children and adolescents appeared to be 
associated with parental depression status (Chi-square P-value <0.0001). Around 10% of 
children and adolescents did not receive any treatment after their depression diagnosis, 
regardless of their parents’ depression status. Nonetheless, 35.56% of children and 
adolescents with depressed parents received only psychotherapy, more than 13% lower 
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than those without depressed parents. In contrast, the proportion of children and 
adolescents with depressed parents that had received combination treatment (43.23%) was 
nearly 12% higher than those without (31.79%).  
Significant differences in the types of depression treatment were also observed with 
regards to the number of depressed children in the household. 17.75% of depressed children 
and adolescents living with siblings with a depression diagnosis did not receive any 
depression treatment, a number that was almost double that of those who were the only 
ones with a depression diagnosis. 49.13% of those from families of more than one 
depressed child and/or adolescents received psychotherapy only following the initial 
diagnosis, higher than that of their counterpart (42.87%), while 24.03% of them were 
prescribed with the combination treatment, substantially lower than their counterpart 
(37.17%).  
3.2. Individual factors – age, gender, comorbidity and depression 
treatment 
Significant differences in children and adolescents’ age were observed between 
each pair of depression treatments. Over 75% of young children aged 3 to 5 with depression 
received psychotherapy only following their initial diagnosis, which was considerably 
higher than other age groups. A reverse pattern was observed with treatment that consisted 
of only medication and the combination treatment. Only 3.83% and 9.03% of children 3 to 
5 years of age were prescribed with antidepressant and combination treatments, 
respectively, while a lot more adolescents were engaged in these treatments.  
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Limited gender difference was observed in those who received pharmacotherapy 
only and those who received no treatment at all. However, more males (46.45%) appeared 
to engage in psychotherapy only compared to females (41.20%), while more females 
(38.69%) than males (33.09%) received both the psychotherapy and antidepressant 
treatments.  
Comorbidities seem to be associated with the choice of depression treatment. 
Significant differences between those with specific comorbidity diagnosis (ADHD, PTSD, 
anxiety disorders, and suicide ideation) and those without were observed in the proportion 
of depressed children and adolescents using psychotherapy and the proportion of those 
using pharmacotherapy (and of those using combination treatment). Combination 
treatment appeared to be the most common choice of initial depression treatment for those 
who were later diagnosed with comorbidities: 39.21% of those with ADHD, 46.73% of 
those with anxiety disorders, 45.16% of those with PTSD and 50.40% of those with suicide 
ideation were treated with combination therapy at first for their depression. Psychotherapy 
ranked as the next common type of treatment. Over 38% of children and adolescents 
diagnosed with ADHD following their depression diagnosis received psychotherapy, 
which was more than 10% higher than the other comorbidity categories.  
3.3. Institutional factors - Health insurance, healthcare providers 
and depression treatment 
Overall, the types of depression treatment that children and adolescents received 
appeared to be associated with the private health insurance plans they were enrolled in. 
However, when comparing between pairs of treatments, significant differences (Appendix 
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Table B.1, Chi-square P-value with Bonferroni correction: 0.0308) were only observed in 
the distribution of insurance plan enrollment between those on psychotherapy and those on 
antidepressant therapy. However, the differences in the proportions were small.  
With respect to the type of provider that prescribed the depression treatment, mental 
health providers had a relatively higher proportion of pharmacotherapy and combination 
treatment prescriptions, and lower proportion of psychotherapy prescriptions, compared to 
primary care providers.  
3.4. Societal factors – region and depression treatment 
Types of depression treatment varied significantly amongst the four U.S. 
geographic regions. 46.82% of children and adolescents living in the Northeast received 
psychotherapy as the treatment for depression, the highest among the other three regions. 
In contrast, 12.21% of those from the South were prescribed antidepressants, higher than 
the other three regions. Midwest and South appeared to have similar proportions of 
combination treatment prescribed, both around 39%, which were more than 5% higher than 
the Northeast and West. 
  
2
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Table 3. Demographic characteristics of the study sample, by type of treatment (N = 35,180) 
 
      
N 
No treatment 
Psychotherapy 
only 
Antidepressant 
only 
Combination 
Chi-
square 
P-value       N % N % N % N % 
Parental depression  
  
    
  
      
No 
 
20,243 2,041 10.08 9,856 48.69 1,911 9.44 6,435 31.79 <0.0001  
Yes 
 
14,937 1,386 9.28 5,312 35.56 1,781 11.92 6,458 43.23  
Number of depressed 
children in the family 
 
  
    
  
     
 
1 child 
 
33,794 3,181 9.41 14,487 42.87 3,566 10.55 12,560 37.17 <0.0001  
More than 1 child 1,386 246 17.75 681 49.13 126 9.09 333 24.03  
Age group 
 
 
  
    
  
      
3 to 5 years  1,019 111 10.89 777 76.25 39 3.83 92 9.03 <0.0001  
6 to 11 years 9,739 1,003 10.3 4,814 49.43 858 8.81 3,064 31.46   
12 to 14 years 15,517 1,481 9.54 6,042 38.94 1,718 11.07 6,276 40.45   
15 to 17 years 8,905 832 9.34 3,535 39.7 1,077 12.09 3,461 38.87  
Gender 
 
 
  
    
  
      
Male 
 
12,851 1,256 9.77 5,969 46.45 1,373 10.68 4,253 33.09 <0.0001  
Female 
 
22,329 2,171 9.72 9,199 41.2 2,319 10.39 8,640 38.69  
Comorbidity 
 
 
  
    
  
      
ADHD 
 
3,634 359 9.88 1,406 38.69 444 12.22 1,425 39.21 <0.0001  
Anxiety disorders 4,924 505 10.26 1,356 27.54 762 15.48 2,301 46.73   
PTSD 
 
558 72 12.9 140 25.09 94 16.85 252 45.16   
Suicide ideation 502 63 12.55 114 22.71 72 14.34 253 50.4  
 
 
  
  
3
0
 
Table 3. Demographic characteristics of the study sample, by type of treatment (N = 35,180) (Cont’d) 
 
      
N 
No treatment Psychotherapy only Antidepressant only Combination Chi-
square 
P-value 
      
N % N % N % N % 
Insurance plan 
 
 
  
    
  
      
PPO 
 
24,471 2,427 9.92 10,653 43.53 2,523 10.31 8,868 36.24 0.0088  
HMO 
 
6,394 592 9.26 2,663 41.65 681 10.65 2,458 38.44   
CDHP 
 
2,628 233 8.87 1,116 42.47 298 11.34 981 37.33   
HDHP 
 
1,687 175 10.37 736 43.63 190 11.26 586 34.74  
Provider type 
 
 
  
    
  
      
Mental health providers 27,654 2,534 9.16 11,925 43.12 2,889 10.45 10,306 37.27 <0.0001  
Primary care providers 3,512 356 10.14 1,708 48.63 335 9.54 1,113 31.69   
Other providers 4,014 537 13.38 1,535 38.24 468 11.66 1,474 36.72  
Region 
 
 
  
    
  
      
Northeast 
 
7,095 805 11.35 3,322 46.82 669 9.43 2,299 32.4 <0.0001  
Midwest 
 
10,774 997 9.25 4,525 42 1,040 9.65 4,212 39.09   
South 
 
9,951 887 8.91 3,962 39.82 1,215 12.21 3,887 39.06  
  West    7,360 738 10.03 3,359 45.64 768 10.43 2,495 33.9   
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4. Multivariate analysis 
Both multivariate logistic regressions and GEE models controlling for the 
clustering of depressed children and adolescents in the same household were used to 
examine the association in the outcome with primary and other study covariates. GEE 
estimates are cited in the following sections (Table 4 – Table 8). Results from the 
multivariate logistic regression are listed in the Appendix Tables B.2 – B.5. 
4.1. Interpersonal factors - Parental depression, number of 
depressed children in the family and depression treatment  
4.1.1 Any treatment 
As shown in Table 4, depressed children and adolescents with parents diagnosed 
with depression were 13% more likely (aOR: 1.13, 95% CI: (1.05, 1.21)) to receive any 
treatment for depression, compared to those without. This finding supports our first 
hypothesis that depressed children and adolescents with parents also diagnosed with 
depression would be more likely to receive depression treatment, compared to those 
without parents diagnosed with depression.  
Depressed children and adolescents living with siblings who also had depression 
were less than half as likely to receive any kind of depression treatment compared to those 
who were the only depressed child/adolescent in the family (aOR: 0.47, 95% CI: (0.41, 
0.55)).  
4.1.2 Specific types of treatment 
Despite the previous observation that parental depression would have a positive 
association with their children and adolescents’ depression treatment, as shown in Table 
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5a to Table 6c, it appeared that this observation was not consistent across specific types of 
treatment.  
Contrary to the study hypothesis, compared to those without depressed parents, 
depressed children and adolescents with parents diagnosed with depression were 
significantly less likely (aOR: 0.80, 95% CI: (0.74, 0.86)) to use psychotherapy only as 
their treatment for depression. On the other hand, they were 41% and 55% more likely to 
receive pharmacotherapy (aOR: 1.41, 95% CI: (1.28, 1.56)) and combination treatment 
(aOR: 1.95% CI: (1.43, 1.68)) after their initial depression diagnosis, compared to children 
and adolescents without depressed parents.  
 For those who had received treatment for their depression (Table 6a – 6c), after the 
initial depression diagnosis, depressed children and adolescents with parents diagnosed 
with depression, compared to those without, were almost twice as likely to use the 
combination treatment (aOR: 1.98, 95% CI: (1.88, 2.08)), and 1.82 times as likely to use 
antidepressants (aOR: 1.82, 95% CI: (1.69, 1.96)), respectively, over the treatment of 
psychotherapy only. Depressed children and adolescents of parents with depression were 
also 9% more likely to use combination treatment over pharmacotherapy only than their 
counterparts.  
On the other hand, depressed children and adolescents with depressed siblings in 
the same family were at a higher risk of being untreated for their depression than their 
counterparts. Specifically, compared to those who were the only depressed child or 
adolescent in the family, depressed children and adolescents who came from families with 
more than one depressed child or adolescent were less likely to receive psychotherapy 
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(aOR: 0.59, 95% CI: (0.51, 0.69)), less likely to receive pharmacotherapy (aOR: 0.48, 95% 
CI: (0.38, 0.60)), and least likely to receive combination treatments (aOR: 0.35, 95% CI: 
(0.29, 0.41)).  
4.2. Individual factors – age, gender, comorbidity and depression 
treatment 
4.2.1 Any treatment  
This study did not find significant differences between age groups and between 
gender on whether or not the depressed children and adolescents would receive depression 
treatment. (Table 4) Except for PTSD, depressed children and adolescents who were 
diagnosed with the other three mental health comorbidities within 12 months of the initial 
depression diagnosis did not appear to differ on receipt of depression treatment. Those who 
were later diagnosed with PTSD were 25% less likely (aOR: 0.75, 95% CI: (0.58, 0.97)) 
to be treated for their initial depression diagnosis, compared to their counterparts. 
4.2.2 Specific types of treatment 
 Significant trends were observed between age and the likelihood of using 
psychotherapy, pharmacotherapy and combination treatments (test for trend, p-values 
<0.0001). Younger children were substantially more likely to receive psychotherapy only 
to treat their depression, and less likely to receive antidepressants as well as combination 
treatments, compared to teenagers. 
When comparing between different types of treatment, children younger than 12 
years were significantly less likely to be prescribed with antidepressant medications (Age 
3–5, aOR: 0.15, 95% CI: (0.11, 0.21); Age 6–11, aOR: 0.52, 95% CI: (0.47, 0.57)) and 
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with combination treatment (Age 3–5, aOR: 0.11, 95% CI: (0.09, 0.14); Age 6–11, aOR: 
0.57, 95% CI: (0.53, 0.61)) than psychotherapy, compared to adolescents. The difference 
in the likelihood of being prescribed combination treatment over psychotherapy, however, 
was not significant between 12 to 14 years and 15 to 17 years of age.  
Females were 15% more likely (aOR: 1.15, 95% CI: (1.06, 1.24)) to receive 
combination treatment after their first diagnosis of depression, compared to males. Gender 
disparities were not observed in the receipt of the other two types of treatments. In addition, 
combination treatment appeared to be the more popular for girls, as they were 24% more 
likely (aOR: 1.24, 95% CI: (1.18, 1.30)), and 20% more likely (aOR: 1.20, 95% CI: (1.11, 
1.29)), respectively, to choose combination therapy rather than psychotherapy and 
antidepressant medications, compared to boys.  
Further, depressed children and adolescents with comorbidities were less likely to 
receive psychotherapy as initial depression treatment, compared to those without. 
Depressed children and adolescents diagnosed with ADHD were 15% less likely (aOR: 
0.85, 95% CI: (0.75, 0.96)), PTSD 51% less likely (aOR: 0.49, 95% CI: (0.37, 0.66)), 
anxiety disorder 41% less likely (aOR: 0.59, 95% CI: (0.53, 0.67)), and suicidal ideation 
51% less likely (aOR: 0.49, 95% CI: (0.35, 0.67)) to use psychotherapy following their 
initial depression diagnosis, compared to their counterparts, respectively.  
On the other hand, those with comorbidities were 1.36 to 2.59 times as likely as 
those without to receive pharmacotherapy over psychotherapy (ADHD: aOR: 1.36, 95% 
CI: (1.21, 1.54); PTSD: 2.46, 95% CI: (1.85, 3.28); anxiety disorders: aOR: (2.59, 95% CI: 
(2.34, 2.86); suicidal ideation: aOR: 2.08. 95% CI: (1.51, 2.86)). They were 1.27 to 2.25 
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times as likely as those without comorbidities to use combination treatment over 
psychotherapy (ADHD: aOR: 1.27, 95% CI: (1.17, 1.38); PTSD: 1.90, 95% CI: (1.52, 2.38); 
anxiety disorders: aOR: (2.59, 9516 CI: (2.00, 2.33); and suicidal ideation: aOR: 2.25. 95% 
CI: (1.77, 2.85)).  
4.3. Institutional factors - Health insurance, healthcare providers 
and depression treatment  
4.3.1 Any treatment 
As shown in Table 4, depressed children and adolescents enrolled in HMO plans 
were 36% more likely to receive any depression treatment from mental health providers 
than from primary care providers. This association was not consistent in the other three 
plan types. Further, there was no significant difference in terms of prescribing any 
treatment by primary care providers as well as mental health providers in other plans (Table 
7). The only exception was with the other providers, which were comprised of practitioners 
other than primary care and mental health providers. Depressed children and adolescents 
were 69% more likely to get any treatment for depression from other providers if they were 
in HMO plans than if they were in PPO plans. (Table 7) 
4.3.2 Specific types of treatment 
Private insurance plans and health care providers did not appear to impose a 
significant impact on using psychotherapy for depressed children and adolescents. (Table 
5a, Table 8)  
As shown in Table 5b, with regards to pharmacotherapy, for depressed children and 
adolescents in HMO plans, they were 1.81 times as likely to receive a prescription for 
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antidepressants from mental health providers as from primary care providers (aOR: 1.81, 
95% CI: (1.22, 2.70)). Mental health providers were also more likely than primary care 
providers to prescribe pharmacotherapy over psychotherapy to HMO- and CDHP-enrolled 
depressed children and adolescents (Table 6a; HMO: aOR: 1.77, 95% CI: (1.25, 2.50); 
CDHP: aOR: 2.24, 95% CI: (1.28, 3.93)).  
When seeing primary care providers (Table 8), depressed children and adolescents 
enrolled in HMOs were substantially less likely to receive prescriptions for antidepressants 
compared to their peers enrolled in PPOs (aOR: 0.60, 95% CI: (0.40, 0.91)). However, 
when seeing mental health providers, in contrast, HMO-enrolled depressed children and 
adolescents were 25% more likely to receive pharmacotherapy over psychotherapy, 
compared to their PPO-enrolled peers.  
Lastly for combination treatment, depressed children and adolescents in HMO 
plans were 80% more likely to receive both antidepressant and psychotherapy from mental 
health providers than from primary care providers (aOR: 1.80, 95% CI: (1.35, 2.41)). In 
addition, as presented in Table 6b, mental health providers were significantly more likely 
than primary care providers to prescribe combination treatment over psychotherapy only 
to depressed children and adolescents in PPO (aOR: 1.23, 95% CI: (1.11, 1.36)), HMO 
(aOR: 1.69, 95% CI: (1.38, 2.08)) and CDHP (aOR: 1.43, 95% CI: (1.05, 1.95)). 
Nonetheless, only in PPO plans were mental health providers significantly more likely than 
primary care providers to prescribe combination therapy over pharmacotherapy (aOR: 1.21, 
95% CI: (1.04, 1.41)). 
4.4. Societal factors – region and depression treatment 
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4.4.1 Any treatment 
Patterns of depression treatment prescription appeared to differ by U.S. geographic 
regions. (Table 4) Depressed children and adolescents in the Midwest and those in the 
South were 19% (aOR: 1.20, 95% CI: (1.09, 1.32)) and 24% (aOR: 1.26, 95% CI: (1.14, 
1.40)), more likely to receive depression treatment, compared to their peers in the Northeast, 
respectively.  
4.4.2 Specific types of treatment 
As shown in Table 5a, use of psychotherapy did not appear to differ by geographic 
region. In contrast in Table 5b, compared to those from the Northeast, depressed children 
and adolescents from the other three regions were more likely to be prescribed with 
antidepressants to treat depression. Similar patterns were also observed in the receipt of 
combination treatment, where Midwestern (aOR: 1.43, 95% CI: (1.28, 1.59)) and Southern 
(aOR: 1.51, 95% CI: (1.35, 1.69)) depressed children and adolescents were more likely to 
use combination treatment than their Northeastern peers. The likelihood of receiving 
antidepressant medications over psychotherapy in depressed children and adolescents in 
the Midwest (aOR: 1.17, 95% CI: (1.05, 1.31)), South (aOR: 1.61, 95% CI: (1.44, 1.79)) 
and West (aOR: 1.14, 95% CI: (1.01, 1.28)) were all higher than those in the Northeast, 
with South being the highest.  
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Table 4. Likelihood of using any treatment for depression vs. no treatment    
Adjusted OR 95% CI 
Parental depression 
   
 
Yes 
 
1.13* (1.05, 1.21)  
No 
 
Reference 
Number of depressed children in the family 
   
 
1 child 
 
Reference  
More than 1 child 0.47* (0.41, 0.55)       
Age group 
    
 
3 to 5 years 0.84 (0.68, 1.04)  
6 to 11 years 0.91 (0.83, 1.00)  
12 to 14 years 0.98 (0.90, 1.08)  
15 to 17 years Reference 
Gender 
    
 
Male 
 
Reference  
Female 
 
1.01 (0.93, 1.08) 
Comorbidity 
    
 
ADHD (Ref: no ADHD) 0.98 (0.87, 1.10)  
PTSD (ref: no PTSD) 0.75* (0.58, 0.97)  
Anxiety disorders (Ref: no anxiety disorders) 0.94 (0.85, 1.04)  
Suicide ideation (ref: no suicide ideation) 0.76 (0.58, 1.00)       
Insurance plan and Provider type 
   
 
PPO Primary care provider Reference   
Mental health provider 1.01 (0.87, 1.17)   
Other provider 0.60* (0.51, 0.72)  
HMO Primary care provider Reference   
Mental health provider 1.36* (1.05, 1.77)   
Other provider 1.27 (0.91, 1.76)  
CDHP Primary care provider Reference   
Mental health provider 1.00 (0.63, 1.57)   
Other provider 0.82 (0.45, 1.49)  
HDHP Primary care provider Reference   
Mental health provider 1.18 (0.76, 1.81)   
Other provider 0.81 (0.44, 1.49)       
Region 
  
 
Northeast 
 
Reference  
Midwest 
 
1.20* (1.09, 1.33)  
South 
 
1.26* (1.14, 1.40)  
West  
 
1.07 (0.96, 1.20) 
Note: *P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
generalized estimating equation (GEE) models controlling for the clustering of depressed children and 
adolescents in the same household.
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Table 5a. Likelihood of using specific treatment for depression (psychotherapy) vs. 
no treatment    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  0.80* (0.74, 0.86) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.59* (0.50, 0.69) 
Age group  
   
 3 to 5 years 1.67* (1.35, 2.07) 
 6 to 11 years 1.20* (1.08, 1.33) 
 12 to 14 years 1.00 (0.91, 1.10) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  0.93 (0.86, 1.01) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 0.85* (0.75, 0.96) 
 PTSD (ref: no PTSD) 0.49* (0.37, 0.66) 
 Anxiety disorders (Ref: no anxiety disorders) 0.59* (0.53, 0.67) 
 Suicide ideation (ref: no suicide ideation) 0.49* (0.35, 0.67) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 0.94 (0.80, 1.10) 
  Other provider 0.52* (0.43, 0.63) 
 HMO Primary care provider Reference 
  Mental health provider 1.05 (0.80, 1.40) 
  Other provider 0.98 (0.69, 1.39) 
 CDHP Primary care provider Reference 
  Mental health provider 0.79 (0.49, 1.26) 
  Other provider 0.57 (0.30, 1.09) 
 HDHP Primary care provider Reference 
  Mental health provider 1.08 (0.68, 1.72) 
  Other provider 0.70 (0.36, 1.35) 
Region   
   
 Northeast Reference 
 Midwest 1.05 (0.94, 1.17) 
 South  1.03 (0.92, 1.15) 
 West   1.03 (0.91, 1.15) 
Note: *P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
generalized estimating equation (GEE) models controlling for the clustering of depressed children and 
adolescents in the same household.
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Table 5b. Likelihood of using specific treatment for depression (pharmacotherapy) 
vs. no treatment    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.41* (1.28, 1.56) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.48* (0.38, 0.61) 
Age group  
   
 3 to 5 years 0.26* (0.18, 0.38) 
 6 to 11 years 0.63* (0.55, 0.72) 
 12 to 14 years 0.88* (0.79, 0.99) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  0.95 (0.86, 1.05) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.20* (1.03, 1.40) 
 PTSD (ref: no PTSD) 1.24 (0.89, 1.71) 
 Anxiety disorders (Ref: no anxiety disorders) 1.50* (1.32, 1.71) 
 Suicide ideation (ref: no suicide ideation) 0.97 (0.68, 1.39)      
Insurance plan and Provider type 
 
 PPO Primary care provider Reference 
  Mental health provider 0.96 (0.79, 1.16) 
  Other provider 0.66* (0.52, 0.83) 
 HMO Primary care provider Reference 
  Mental health provider 1.81* (1.22, 2.70) 
  Other provider 1.79* (1.12, 2.88) 
 CDHP Primary care provider Reference 
  Mental health provider 1.70 (0.85, 3.43) 
  Other provider 1.32 (0.55, 3.19) 
 HDHP Primary care provider Reference 
  Mental health provider 1.38 (0.72, 2.62) 
  Other provider 1.38 (0.60, 3.21) 
Region  
    
 Northeast Reference 
 Midwest 1.21* (1.06, 1.40) 
 South  1.64* (1.42, 1.88) 
 West   1.18* (1.02, 1.38) 
Note:  
*P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
generalized estimating equation (GEE) models controlling for the clustering of depressed children and 
adolescents in the same household.
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Table 5c. Likelihood of using specific treatment for depression (combination 
treatment) vs. no treatment    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.55* (1.43, 1.68) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.35* (0.29, 0.42) 
Age group  
   
 3 to 5 years 0.19* (0.14, 0.26) 
 6 to 11 years 0.70* (0.63, 0.78) 
 12 to 14 years 0.99 (0.90, 1.09) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  1.15* (1.06, 1.24) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.09 (0.96, 1.24) 
 PTSD (ref: no PTSD) 0.93 (0.70, 1.22) 
 Anxiety disorders (Ref: no anxiety disorders) 1.25* (1.12, 1.39) 
 Suicide ideation (ref: no suicide ideation) 1.01 (0.75, 1.35) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 1.13 (0.96, 1.33) 
  Other provider 0.68* (0.56, 0.83) 
 HMO Primary care provider Reference 
  Mental health provider 1.80* (1.35, 2.41) 
  Other provider 1.69* (1.18, 2.44) 
 CDHP Primary care provider Reference 
  Mental health provider 1.18 (0.72, 1.95) 
  Other provider 1.14 (0.59, 2.21) 
 HDHP Primary care provider Reference 
  Mental health provider 1.18 (0.74, 1.88) 
  Other provider 0.68 (0.35, 1.34) 
Region   
   
 Northeast Reference 
 Midwest 1.43* (1.28, 1.59) 
 South  1.51* (1.35, 1.69) 
 West   1.10 (0.98, 1.25) 
Note:  
*P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
generalized estimating equation (GEE) models controlling for the clustering of depressed children and 
adolescents in the same household.
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Table 6a. Likelihood of using pharmacotherapy vs. psychotherapy 
    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.82* (1.68, 1.96) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.77* (0.61, 0.97) 
Age group  
   
 3 to 5 years 0.15* (0.11, 0.21) 
 6 to 11 years 0.52* (0.47, 0.57) 
 12 to 14 years 0.87* (0.80, 0.95) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  1.03 (0.95, 1.11) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.36* (1.21, 1.54) 
 PTSD (ref: no PTSD) 2.46* (1.85, 3.28) 
 Anxiety disorders (Ref: no anxiety disorders) 2.59* (2.34, 2.86) 
 Suicide ideation (ref: no suicide ideation) 2.08* (1.51, 2.86) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 1.02 (0.88, 1.18) 
  Other provider 1.29* (1.07, 1.56) 
 HMO Primary care provider Reference 
  Mental health provider 1.77* (1.25, 2.50) 
  Other provider 1.91* (1.28, 2.85) 
 CDHP Primary care provider Reference 
  Mental health provider 2.24* (1.28, 3.93) 
  Other provider 2.23* (1.08, 4.60) 
 HDHP Primary care provider Reference 
  Mental health provider 1.40 (0.82, 2.36) 
  Other provider 2.75* (1.39, 5.42) 
Region   
   
 Northeast Reference 
 Midwest 1.17* (1.04, 1.32) 
 South  1.64* (1.46, 1.83) 
 West   1.16* (1.03, 1.31) 
Note:  
*P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
generalized estimating equation (GEE) models controlling for the clustering of depressed children and 
adolescents in the same household.
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Table 6b. Likelihood of using combination treatment vs. psychotherapy 
    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.98* (1.88, 2.08) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.56* (0.47, 0.65) 
Age group  
   
 3 to 5 years 0.11* (0.09, 0.14) 
 6 to 11 years 0.57* (0.53, 0.61) 
 12 to 14 years 0.99 (0.93, 1.05) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  1.24* (1.18, 1.30) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.27* (1.17, 1.38) 
 PTSD (ref: no PTSD) 1.90* (1.52, 2.38) 
 Anxiety disorders (Ref: no anxiety disorders) 2.16* (2.00, 2.33) 
 Suicide ideation (ref: no suicide ideation) 2.25* (1.77, 2.85) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 1.23* (1.11, 1.36) 
  Other provider 1.38* (1.21, 1.57) 
 HMO Primary care provider Reference 
  Mental health provider 1.69* (1.38, 2.08) 
  Other provider 1.76* (1.37, 2.25) 
 CDHP Primary care provider Reference 
  Mental health provider 1.43* (1.05, 1.95) 
  Other provider 1.87* (1.21, 2.87) 
 HDHP Primary care provider Reference 
  Mental health provider 1.12 (0.82, 1.53) 
  Other provider 1.22 (0.75, 1.98) 
Region   
   
 Northeast Reference 
 Midwest 1.38* (1.28, 1.48) 
 South  1.49* (1.38, 1.61) 
 West   1.07 (0.99, 1.16) 
Note:  
*P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
generalized estimating equation (GEE) models controlling for the clustering of depressed children and 
adolescents in the same household.
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Table 6c. Likelihood of using combination treatment vs. pharmacotherapy 
    
Adjusted OR 95% CI 
Parental depression  
   
 Yes  1.09* (1.01, 1.17) 
 No  Reference 
Number of depressed children in the family 
  
 1 child  Reference 
 More than 1 child  0.74* (0.59, 0.93) 
Age group  
   
 3 to 5 years  0.81 (0.55, 1.20) 
 6 to 11 years  1.12* (1.01, 1.25) 
 12 to 14 years  1.13* (1.04, 1.24) 
 15 to 17 years  Reference 
Gender  
   
 Male  Reference 
 Female  1.20* (1.11, 1.29) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 0.94 (0.84, 1.05) 
 PTSD (ref: no PTSD) 0.74* (0.58, 0.94) 
 Anxiety disorders (Ref: no anxiety disorders) 0.82* (0.75, 0.90) 
 Suicide ideation (ref: no suicide ideation) 1.00 (0.77, 1.30) 
Insurance plan and Provider type 
   
 PPO Primary care provider Reference 
  Mental health provider 1.21* (1.04, 1.41) 
  Other provider 1.03 (0.85, 1.25) 
 HMO Primary care provider Reference 
  Mental health provider 0.96 (0.68, 1.36) 
  Other provider 0.92 (0.61, 1.37) 
 CDHP Primary care provider Reference 
  Mental health provider 0.62 (0.36, 1.09) 
  Other provider 0.83 (0.41, 1.67) 
 HDHP Primary care provider Reference 
  Mental health provider 0.80 (0.48, 1.34) 
  Other provider 0.45* (0.23, 0.88) 
Region  
   
 Northeast  Reference 
 Midwest  1.15* (1.03, 1.29) 
 South  0.91 (0.82, 1.02) 
 West   0.92 (0.82, 1.04) 
Note:  
*P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
generalized estimating equation (GEE) models controlling for the clustering of depressed children and 
adolescents in the same household.
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Table 7. Association of the interaction between insurance plan and provider type with any depression treatment 
 
 Adjusted 
OR 
95% CI 
Insurance plan and Provider type    
Primary care provider PPO Reference   
HMO 0.80 (0.61, 1.06)   
CDHP 1.08 (0.69, 1.70)   
HDHP 0.82 (0.54, 1.24)  
Mental health provider PPO Reference   
HMO 1.08 (0.97, 1.21)   
CDHP 1.06 (0.91, 1.25)   
HDHP 0.96 (0.79, 1.16)  
Other provider PPO Reference   
HMO 1.69* (1.32, 2.17)   
CDHP 1.46 (0.95, 2.25)   
HDHP 1.11 (0.69, 1.78) 
 
Note:  
*P-value < 0.05 
aOR (adjusted odds ratios) were calculated from the respective GEE models listed in Tables 4 by changing the reference level of the main effects 
and interaction of insurance plan and provider types.
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Table 8. Association of the interaction between insurance plan and provider type with depression treatment 
   
Psychotherapy only vs. no 
treatment 
Pharmacotherapy only vs. no 
treatment 
Combination treatment vs. 
no treatment 
  aOR 95% CI aOR 95% CI aOR 95% CI 
Insurance plan and Provider type 
       
Primary 
care 
provider 
PPO Reference Reference Reference 
HMO 0.86 (0.64, 1.16) 0.60* (0.40, 0.91) 0.74 (0.54, 1.01) 
CDHP 1.22 (0.76, 1.94) 0.67 (0.33, 1.35) 1.01 (0.62, 1.66) 
HDHP 0.82 (0.53, 1.28) 0.74 (0.40, 1.38) 0.88 (0.56, 1.36) 
Mental 
health 
provider 
PPO Reference Reference Reference 
HMO 0.97 (0.86, 1.09) 1.14 (0.98, 1.32) 1.18* (1.05, 1.33) 
CDHP 1.02 (0.87, 1.21) 1.19 (0.97, 1.47) 1.06 (0.89, 1.26) 
HDHP 0.95 (0.78, 1.17) 1.07 (0.82, 1.38) 0.92 (0.74, 1.13) 
Other 
provider 
PPO Reference Reference Reference 
HMO 1.62* (1.24, 2.10) 1.64* (1.18, 2.28) 1.83* (1.40, 2.40) 
CDHP 1.34 (0.84, 2.16) 1.35 (0.75, 2.44) 1.69* (1.05, 2.72) 
HDHP 1.11 (0.66, 1.86) 1.57 (0.85, 2.89) 0.88 (0.51, 1.51) 
 
Note: *P-value < 0.05. aOR (adjusted odds ratios) were calculated from the respective GEE models listed in Tables 5a – 6c by changing the 
reference level of the main effects and interaction of insurance plan and provider types. 
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Table 8. Association of the interaction between insurance plan and provider type with depression treatment (Cont’d) 
   
Pharmacotherapy only vs. 
psychotherapy only 
Combination treatment vs. 
psychotherapy only 
Combination therapy vs. 
pharmacotherapy only 
  aOR 95% CI aOR 95% CI aOR 95% CI 
Insurance plan and Provider type 
       
Primary 
care 
provider 
PPO Reference Reference Reference 
HMO 0.72 (0.50, 1.03) 0.92 (0.74, 1.13) 1.26 (0.88, 1.81) 
CDHP 0.55* (0.31, 0.96) 0.88 (0.65, 1.20) 1.67 (0.96, 2.91) 
HDHP 0.82 (0.49, 1.36) 1.01 (0.75, 1.37) 1.34 (0.81, 2.20) 
Mental 
health 
provider 
PPO Reference Reference Reference 
HMO 1.25* (1.12, 1.40) 1.26* (1.17, 1.36) 1.00 (0.90, 1.12) 
CDHP 1.20* (1.03, 1.40) 1.03 (0.93, 1.15) 0.86 (0.74, 1.00) 
HDHP 1.12 (0.91, 1.37) 0.93 (0.81, 1.06) 0.89 (0.73, 1.08) 
Other 
provider 
PPO Reference Reference Reference 
HMO 1.07 (0.82, 1.39) 1.17 (0.98, 1.40) 1.12 (0.86, 1.45) 
CDHP 0.95 (0.58, 1.55) 1.20 (0.86, 1.67) 1.34 (0.85, 2.14) 
HDHP 1.74* (1.07, 2.83) 0.90 (0.60, 1.34) 0.58* (0.35, 0.95) 
 
Note: *P-value < 0.05. aOR (adjusted odds ratios) were calculated from the respective GEE models listed in Tables 5a – 6c by changing the 
reference level of the main effects and interaction of insurance plan and provider types 
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 DISCUSSION  
Using the most recent insurance claims data from MarketScan Commercial Claims 
and Encounters database (2010 – 2014), this study followed a conceptual framework built 
on the ecological and Andersen models to examine the multiple individual, interpersonal, 
institutional and societal factors on depressed children and adolescents’ depression 
treatment.  
1. Interpersonal factors - parental depression and number of depressed 
children in the family  
1.1. Parental depression 
Previous literature has documented that children as well as adolescents with parents 
diagnosed with depression are at a higher risk of developing depression.19 It is unclear, 
however, how parental depression influences the management of depression in children 
and adolescents. Findings from this study contribute to the literature by evaluating the 
important role parental depression plays in their depressed offspring’s treatment of 
depression.  
The observation that parental depression would have an overall positive impact on 
their depressed children and adolescents’ depression treatment confirms the study’s 
primary hypothesis and is consistent with previous research on overall health services 
utilization. Increased utilization of healthcare services, including visits to emergency 
rooms, hospitalization,54 and mental health services,23 have been observed in particular for 
young children with depressed parents.19,23 However, limited evidence exists to 
demonstrate the association between parental depression and health services utilization in 
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older children and adolescents.19 Pfefferie et al. found that poor self-rated maternal mental 
health status was associated with increased odds of child’s mental health visits with data 
from 2002 National Survey of America’s Family (NSAF) Focal Child File.28 Sills et al. 
reported higher use of emergency department, inpatient and specialty services for children 
enrolled in Kaiser Permanente of Colorado with at least one depressed parent.54 Analyses 
with the National Health Interview Survey (NHIS 1997–2004) by Guevara et al. found 
similar results.55 In addition, previous literature documented that mothers with significant 
depressive symptoms would be more likely to report their young children’s health as 
relatively worse and to seek medical care for somatic disorders.29,30 Therefore, it is not 
surprising that depressed children and adolescents with parents with depression would have 
a comparatively higher likelihood of utilizing health services to treat depression.  
On the other hand, the impact of parental depression on the use of depression 
treatment in their depressed children and adolescents might be partially driven by parents’ 
perceived stigma. In a study by Turner et al., parents who had previously used mental health 
services expressed comparatively less stigma associated with children’s use of mental 
health services.56 Another recent study by Gronholm et al. in the U.K. also found that 
parents and/or caregivers’ stigmatizing behaviors towards and their personal exposures to 
mental health services significantly influenced the children and adolescents’ mental health 
service use.35 Although these studies largely focused on mental health disorders and mental 
health services in general, it is reasonable to postulate that parents who had depression 
themselves would have less stigma with depression and depression treatment through 
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personal experiences and thereby more willing to have their depressed children and 
adolescents engaged in depression treatment.   
More importantly, this study compared three types of depression treatments and 
revealed significant differences in terms of the occurrence of parental depression and their 
associations with different depression treatments in children in the same households with 
depression. Depressed children and adolescents with parents of depression were less likely 
to use psychotherapy, and more likely to use pharmacotherapy and combination treatment, 
compared to those without. This difference may to some extent be driven by the severity 
of the depression.19,36 Studies showed that compared to their peers with no depressed 
parents, depression in children with depressed parents were associated with more severe 
impairment and had longer duration and higher odds of recurrence.19 Clinical use of 
antidepressants in adolescents was strongly linked to serious signs of depression, including 
severe distress, impairment and suicidality.36 As depressed children and adolescents with 
parents also diagnosed with depression may display more serious disorders, they would 
have a higher likelihood to be prescribed antidepressants, compared to their peers without 
depressed parents.  
However, research on the comparative efficacy of psychotherapy, 
pharmacotherapy, and combination treatment as demonstrated by previous research has 
been limited, mixed and mainly concentrated on their short-term effectiveness.10,15 
Hence, there might be other factors involved driving the difference in the selection of 
depression treatment between depressed children with and without depressed parents. 
Parental engagement might be one of the factors. Parents diagnosed with depression have 
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been shown in many previous studies to have less supportive parental behaviors in 
interacting with their children and adolescents. Depression leads to more negative 
parenting styles represented by unresponsiveness and avoidance to the children’s 
needs.25,26,37 With respect to depression treatment, psychotherapy might require extra 
time and effort from parents to routinely take their children to the therapists, while filling 
an antidepressant could be more easily done at a local clinic or pharmacy. As parents 
with depression may be more prone to withdrawal from their children’s healthcare needs, 
they might be more willing to select the type of treatment that is less demanding. Future 
research is needed to evaluate the pathway of parental engagement as well as other 
parental characteristics involved in the care of depression for their offspring.  
1.2. Number of depressed children and adolescents in the family  
Another interesting finding from this study is the association between the number 
of depressed children and adolescents in the family and depression treatment. Depressed 
children and adolescents from families with more than one depressed child were 
significantly less likely to obtain treatment for their depression, compared with those who 
were with only one depressed child in the family. Supplemental analysis was conducted on 
the interaction between parental depression and number of depressed children and 
adolescents in the family. Regardless of parental depression status, depressed children and 
adolescents with siblings also diagnosed with depression were less likely to receive 
depression treatment than those who were the only depressed child in the family.  
Excessive economic burden on the family due to depression might contribute to 
this concerning observation. Mandell et al. compared the 3-year medical expenditures 
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between Medicaid-enrolled children with depression and those with no psychiatric 
disorders. They found that the former group was associated with on average $6,688 in 
medical expenditures, which was more than 40-fold of the latter group ($160).57 Another 
school-based study also suggested that students with depression would have a significantly 
higher total expenditure on mental health care, compared with students with other 
diagnoses.58 There is limited nationally representative data on estimated cost of depression 
in children and adolescents.59 However, based on the existing literature, families with 
multiple depressed offspring may face substantial economic burden.59 As a consequence, 
depressed children and adolescents with siblings also suffering from depression may not 
have adequate access to depression treatment.  
2. Individual factors – age, gender and comorbidity  
Findings from this study suggest that young children were more prone to receive 
psychotherapy to treat their depression, compared with their older peers. The observable 
trend was that as they aged, they became more likely to receive prescriptions for treatment 
involved with antidepressants. Overall, this trend is in accordance with a previous report 
on the national rates of antidepressant use in children and adolescents.60,61 It also reflects a 
more conservative approach in treating depression in young children,9 as no 
antidepressants have been approved by the FDA to be appropriate in treating depression 
under the age of 8 years.  
Research has thoroughly documented the divergence in the incidence of depression 
between girls and boys, especially at the beginning of adolescence. But there is lack of 
consistent findings on the rates of antidepressant use in boys and girls.60,61 In this study, 
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girls were more likely to use combination therapy over the other two types of treatment 
than boys. Gender disparities, however, were not observed in the use of psychotherapy 
alone and pharmacotherapy alone. Bennett at al. found no substantial gender differences in 
adolescents’ depressive symptoms in general, although depressed adolescent girls were 
more prone to sadness or depressed mood, guilt, feelings of failure, etc. 62 Another study 
also reported that depressed girls more often than boys reported worthlessness and guilt.63 
These differences may lead to different clinical indications for depression treatment, but 
more research is needed to evaluate if there are gender-specific symptoms in childhood and 
adolescent depression and how this might impact treatment options.  
Another notable finding from this study is in those with mental health comorbidities. 
Compared to depressed children and adolescents who were not diagnosed with 
comorbidities examined in this study, those who were later diagnosed were more likely to 
receive antidepressant and combination treatment over psychotherapy. Comorbidities 
serve as an important proxy indicator of illness complexity in those with depression.38 A 
previous study documented that depressed adolescents’ use of antidepressants was strongly 
linked to the severity of the disorder.36 Depressed children and adolescents with 
comorbidities may receive treatment involving antidepressants due to their greater clinical 
need.36  
3. Institutional factors - Health insurance and healthcare providers  
Findings on the impact of health insurance and healthcare providers on use of 
depression treatment largely corroborate with previous publications. In terms of insurance 
arrangements, depressed children and adolescents enrolled in HMO plans were more likely 
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to receive antidepressant treatments than peers in PPO plans. PPO plans in general are more 
flexible than HMO plans and requires no prior approval in prescribing certain medications.9 
As a consequence, providers in HMO plans may be more likely to abide by formulary 
guidelines and other quality measures and prescribe recommended treatments.9,44 
Furthermore, study results indicated that in most plans, mental health providers 
were more prone to prescribe pharmacotherapy and combination therapy over 
psychotherapy than primary care providers. This corroborates with prior studies where 
provider specialty was recognized as an important factor in child/adolescent’s depression 
treatment selection.9,64 A survey conducted by the AAP indicated that 88% of the 
pediatricians believed they should be responsible in identifying childhood and adolescents’ 
depression, but only 25% agreed that it was their responsibility to treat and manage the 
disorder.65 Primary care providers often lack the experience and training necessary in the 
treatment of depression in children and adolescents, and are therefore reluctant to prescribe 
antidepressants,66–69 unless they have substantial specialized knowledge about depression 
or access to mental health specialists.69,70 Current incentives for primary care providers to 
provide psychotherapy in those that are trained may not be adequate to reimburse for the 
time and labor such therapy demands.71 
This study also assessed CDHP and HDHP, two types of popular employer-
sponsored insurance arrangements. This study found significant differences between 
CDHP and PPO on their impact on depressed children and adolescents’ use of depression 
treatment, but not in HDHP. Some CDHPs may carve out medications in the plan’s 
deductible arrangement. Insurance plan’s coverage for certain medications may influence 
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consumer’s choice to use pharmacotherapy due to concerns with expenditures. However, 
as there is limited information on detailed plan features in the database to identify the 
coverage for antidepressant medications with the list of antidepressants, it is challenging 
to explain the findings. This study did not find significant differences between HDHP and 
PPO on their impact on depressed children and adolescents’ use of depression treatment.  
4. Societal factor – region  
Geographic differences were observed in depressed children and adolescents’ use 
of antidepressant and combination treatment, but were not consistent with previous studies. 
Merikangas et al. did not find significant differences between geographic regions in those 
receiving antidepressants among depressed adolescents aged 13 to 18.72 However, Soria-
Saucedo and colleagues found evidence for significantly less use of first line 
antidepressants and psychotherapy in depressed children and adolescents from the South 
compared to the Northeast.9 Conflicting findings from the current study in terms of 
geographic disparities warrant further investigation.  
5. Implications 
To the author’s knowledge, this is the first study that assessed the influence of 
parental depression on privately-insured depressed children and adolescents’ use of 
specific depression treatment. Findings supported the study hypotheses and were consistent 
with previous research on overall health services use, but future research is certainly 
needed to confirm these findings.  
This study indicated that depressed children and adolescents with parents also 
diagnosed with depression had higher odds of being treated, compared to their peers 
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without depressed parents. Future research is needed to delineate the pathways of the 
observed associations. For example it can be postulated that children and adolescents with 
depressed parents may be at higher risk of developing psychological distress and 
impairment, and that use of pharmacotherapy to treat depression maybe associated with the 
complexity of the depression. In this context the severity of the depression may work as a 
mediator impacting on parental depression and on the use of depression treatment in 
children. Also, it would be important to evaluate how parenting styles and family resources 
would be involved in this process. Providers’ evaluation of the depressed children’s needs 
could also play a role. Future work may collect data on these covariates and analyze how 
they are associated with one another to impact depressed children and adolescents’ use of 
depression treatment through methods such as structural equation modeling. 
The outcome of the study focused on depression treatments that were prescribed 
after initial depression diagnosis. Dosage of the antidepressants, as well as duration of 
psychotherapy treatment were not evaluated as part of the study. It is unknown whether 
depressed children and adolescents with depressed parents would be more adherent to 
psychotherapy and antidepressant medication regimens or not. Depression, as a chronic 
disorder, demands long-term treatment with careful monitoring. It would be crucial to 
assess the factors that may facilitate and/or hinder depressed parents’ engagement in their 
children’s care in the long term.  
It should be noted that more than 10% of all of the depressed young children 3 to 5 
years of age in the study sample were prescribed some kind of antidepressant either as the 
sole treatment or in combination with psychotherapy, despite the fact that no 
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antidepressants have been approved by the FDA for the use in young children under 8 years 
of age.5,7–9 It would be helpful to examine the type and dosage of the medication treatment 
to describe the potential misuse and/or overuse of antidepressants in very young children. 
It would be interesting to see if the covariates included in this study, such as demographics, 
mental health comorbidities, provider types and health insurance, are associated with the 
use of antidepressants. Looking forward, future studies may also examine providers’ 
diagnoses and evaluation of the clinical needs of the depressed children and adolescents 
and parents’ perceptions and preferences of the treatment involving antidepressants. 
Factors that contribute to the prescription of antidepressants by providers in the younger 
ages may serve as the target for future intervention studies to reduce unnecessary 
medication use.  
In addition, the finding that depressed children and adolescents from families with 
more than one depressed child were less likely to use any depression treatment raises 
concerns. This study postulated economic burden as a potential barrier for families with 
more than one depressed child/adolescent. Out-of-pocket spending such as copayment and 
coinsurance that families need to put down for their children’s treatment may influence 
parents’ decision regarding children’s depression treatment. Further quantitative studies 
are necessary to investigate the economic impact on families with depressed children and 
adolescents. For example, are depressed children and adolescents living with depressed 
siblings forgoing care due to higher expenses of depression treatment? Also, are insurance 
plan designs useful in lowering the expenses for families so as not to forgo the necessary 
care? More qualitative research also is needed to evaluate in-depth the barriers that these 
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families face, which may be helpful in designing programs to better allocate community 
resources and to empower families to seek care for their depressed children.  
6. Strengths and Limitations 
Previous literature on parental depression focused largely on its impact on 
children’s physical and mental well-being, in addition to general use of health services 
including emergency room use and hospitalizations.23,54 Few studies have explicitly 
examined the specific treatment for depression. This study contributes to the literature by 
examining the impact of parental depression on their depressed children and adolescents’ 
treatment. Moreover, measures of depression disorders in past studies rely for the most part 
on self-report and/or parental judgement, 29-32 which may introduce recall bias. This study 
addressed these limitations and extracted diagnosis of depression with both the CPT codes 
for diagnostic services and ICD-9 codes for diagnoses from recent claims databases (2010 
– 2014), instead of relying on depression or depressive symptoms self-reported in surveys.  
A few limitations should also be noted. This study used MarketScan Commercial 
Claims Database, which included a substantial number of medical claims from people 
covered by the insurance sponsored by their employers. Because the study population were 
employed and privately-insured, the results may not be generalizable to the entire U.S. 
population. In addition, the data source only represents those who sought clinical care. 
Consequently, this study does not intend to make any inference to factors pertinent to the 
privately-insured population that did not make any clinical encounter during the study 
period. 
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There may be important differences between depressed children and adolescents 
with depressed parents and those without depressed parents. Depressed children and 
adolescents with depressed parents may come from families distinctly different from their 
peers without depressed parents. Examples may include a chronically stressful family 
environment, more budget concerns for medical services, fewer options of providers, etc. 
These factors may impact both the depressed children and adolescents in terms of their 
clinical needs, and also impact the treatment they would receive. But these confounding 
factors were not controlled for in the present analysis. Methods such as propensity score 
matching are likely to reduce these biases and improve the validity of the findings in future 
research. 
In determining parental depression, children and adolescents who had depression 
diagnoses but no linkable parents in the database were excluded. This could potentially 
lead to selection bias in our results. Parents who had visited the doctor’s office, and thus 
generated a claim to be linkable, could potentially be the ones who cared more about their 
own health, and subsequently cared more about their children’s health. Depressed children 
and adolescents with parents who did not visit the doctor’s office during the study period 
and as a consequence did not have any medical claims documented in this database were 
not examined. Future work can examine healthy parents without depression but with a 
depressed child and their health seeking behaviors contrasted with the groups already 
evaluated in this reported study. Different dyads can be considered for future research using 
other data bases based upon new data collection efforts.  
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Most studies on parental depression focused on the maternal side. While this study 
did not emphasize maternal depression, it did not differentiate between maternal and 
paternal depression. Therefore, the study does not intend to make any inference with 
regards to the differences between the impact of maternal depression and the impact of 
paternal depression on depressed children and adolescents’ treatment. In addition, given 
the limitations of the database, the study did not have any information to distinguish 
whether the “parent” identified were biological parent or step-parent. It is also possible that 
the “parent” was a family relative or other type of caregivers who can add to the depressed 
children and adolescents as dependents in their health insurance plans.  
Children and adolescents often receive care for depression outside of the clinical 
settings, especially at schools.59,73 This study did not have any data with regards to social 
support, school counseling, in addition to many other potentially important mediators. As 
delineated in the conceptual framework, depressed children and adolescents’ depression 
treatment could be influenced by multiple layers of factors. It is crucial to examine how 
parental depression would influence their children and adolescents’ use of these services 
to help treat depression.  
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 CONCLUSION  
This study advances the knowledge of the impact of parental depression on 
depressed children and adolescents’ treatment. The results of this study contribute to the 
literature by examining multiple layers of potential influences from individual-, 
interpersonal-, institutional, and societal-level factors on depression treatment in children 
and adolescents. This includes the number of depressed children, type of health insurance 
plans and healthcare providers. Findings from this study underscore the need to examine 
the role of parental engagement and the barriers that families may encounter in children 
and adolescents’ depression treatment. The findings also emphasize the importance of 
educating parents on depression treatment for their children and adolescents and to involve 
them in the decision-making process. 
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 APPENDIX A 
Appendix Table A.1. Psychotherapy CPT codes51 
 
Psychotherapy Length (if 
applicable) 
Year  
2010 – 2012 
Year  
2013 – 2014 
Individual Psychotherapy 20–30min 90804 90832 
45–50min 90806 90834 
75–80min 90808 90837 
Interactive Individual 
Psychotherapy 
20–30min 90810, 90823 90832 
45–50min 90812, 90826 90834 
75–80min 90814, 90828 90837 
Family psychotherapy 90846, 90847, 
90849 
90846, 90847, 
90849 
Group psychotherapy 90853 90853 
Interactive group psychotherapy 90857 90853 
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Appendix Table A.2. List of Antidepressants9,53 
  
Active ingredient Proprietary name FDA approval for age under 18 
First-line treatment    
Fluoxetine Prozac Approved for depression treatment in 
age > 8 
Second-line treatment    
Escitalopram Lexapro Approved for depression treatment in 
age 12 –17 for major depression only  
Sertraline Zoloft Approved in age > 6 for obsessive-
compulsive disorder only  
Fluvoxamine Luvox Approved in age > 8 for obsessive-
compulsive disorder only  
Paroxetine Paxil > 18; Not approved for children and 
adolescents < 18  
Citalopram Celexa > 18; Not approved for children and 
adolescents < 19     
Non-evidence-based 
treatment 
  
 
Duloxetine Cymbalta > 18 for major depression; Not approved 
for children and adolescents < 18 
 
Desvenlafaxine Pristiq/Khedezla > 18 for major depression; Not approved 
for children and adolescents < 18  
Venlafaxine Effexor > 18 for major depression; Not approved 
for children and adolescents < 18  
Bupropion Wellbutrin > 18; Not approved for children and 
adolescents < 18  
Mirtazapine Remeron > 18; Not approved for children and 
adolescents < 18  
Milnacipran Savella Not approved in the U.S.  
Aripiprazole Abilify Not approved for children and 
adolescent depression  
Ziprasidone Geodon Not approved for children and 
adolescent depression  
Quetiapine Seroquel Not approved for children and 
adolescent depression  
Risperidone Risperdal Not approved for children and 
adolescent depression  
Olanzapine Zyprexa Not approved for children and 
adolescent depression 
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 APPENDIX B 
Appendix Table B.1. Demographic characteristics of the study sample, multiple comparison between types of treatment      
Chi-square P-value Bonferroni adjusted P-value 
Age group        
No treatment vs. Psychotherapy only 
 
35.25 <.0001 <.0001  
No treatment vs. Antidepressant only 
 
85.11 <.0001 <.0001  
No treatment vs. Psychotherapy and Antidepressant 
 
195.48 <.0001 <.0001  
Psychotherapy only vs. Antidepressant only 
 
258.94 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
754.45 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
13.02 0.0046 0.0275 
Gender 
      
 
No treatment vs. Psychotherapy only 
 
8.59 0.0034 0.0202  
No treatment vs. Antidepressant only 
 
0.22 0.6381 1.0000  
No treatment vs. Psychotherapy and Antidepressant 
 
16.25 <.0001 0.0003  
Psychotherapy only vs. Antidepressant only 
 
5.85 0.0156 0.0935  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
121.95 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
22.60 <.0001 <.0001 
Parental depression 
      
 
No treatment vs. Psychotherapy only 
 
35.67 <.0001 <.0001  
No treatment vs. Antidepressant only 
 
43.74 <.0001 <.0001  
No treatment vs. Psychotherapy and Antidepressant 
 
100.91 <.0001 <.0001  
Psychotherapy only vs. Antidepressant only 
 
221.10 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
649.80 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
3.93 0.0475 0.2849 
 
 
 
 
 
 
  
6
5
 
Appendix Table B.1. Demographic characteristics of the study sample, multiple comparison between type of treatment 
(Cont’d) 
    
Chi-square P-value Bonferroni adjusted P-value 
Number of depressed children in the family 
    
 
No treatment vs. Psychotherapy only 
 
42.66 <.0001 <.0001  
No treatment vs. Antidepressant only 
 
50.88 <.0001 <.0001  
No treatment vs. Psychotherapy and Antidepressant 
 
167.09 <.0001 <.0001  
Psychotherapy only vs. Antidepressant only 
 
8.41 0.0037 0.0224  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
72.76 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
7.35 0.0067 0.0403 
Insurance plan        
No treatment vs. Psychotherapy only 
 
1.84 0.6073 1.0000  
No treatment vs. Antidepressant only 
 
6.80 0.0785 0.4709  
No treatment vs. Psychotherapy and Antidepressant 
 
10.48 0.0149 0.0892  
Psychotherapy only vs. Antidepressant only 
 
5.39 0.1453 0.8715  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
12.78 0.0051 0.0308  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
3.68 0.2984 1.0000 
Provider type 
      
 
No treatment vs. Psychotherapy only 
 
87.05 <.0001 <.0001  
No treatment vs. Antidepressant only 
 
18.78 <.0001 0.0005  
No treatment vs. Psychotherapy and Antidepressant 
 
61.07 <.0001 <.0001  
Psychotherapy only vs. Antidepressant only 
 
31.43 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
60.59 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
5.45 0.0654 0.3926 
Region 
      
 
No treatment vs. Psychotherapy only 
 
4.23 0.2379 1.0000  
No treatment vs. Antidepressant only 
 
55.45 <.0001 <.0001  
No treatment vs. Psychotherapy and Antidepressant 
 
79.78 <.0001 <.0001  
Psychotherapy only vs. Antidepressant only 
 
75.14 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
142.12 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
28.67 <.0001 <.0001 
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Appendix Table B.1. Demographic characteristics of the study sample, multiple comparison between type of treatment 
(Cont’d)      
Chi-square P-value Bonferroni adjusted P-value 
Comorbidity: ADHD 
      
 
No treatment vs. Psychotherapy only 
 
4.73 0.0296 0.1775  
No treatment vs. Antidepressant only 
 
4.27 0.0388 0.2329  
No treatment vs. Psychotherapy and Antidepressant 
 
0.93 0.3361 1.0000  
Psychotherapy only vs. Antidepressant only 
 
25.50 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
24.42 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
2.72 0.0991 0.5945 
Comorbidity: PTSD 
      
 
No treatment vs. Psychotherapy only 
 
34.42 <.0001 <.0001  
No treatment vs. Antidepressant only 
 
1.55 0.2137 1.0000  
No treatment vs. Psychotherapy and Antidepressant 
 
0.30 0.5850 1.0000  
Psychotherapy only vs. Antidepressant only 
 
63.84 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
53.4 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
4.92 0.0266 0.1597 
Comorbidity: Anxiety 
      
 
No treatment vs. Psychotherapy only 
 
104.27 <.0001 <.0001  
No treatment vs. Antidepressant only 
 
42.34 <.0001 <.0001  
No treatment vs. Psychotherapy and Antidepressant 
 
18.40 <.0001 0.0001  
Psychotherapy only vs. Antidepressant only 
 
407.68 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
487.83 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
14.86 0.0001 0.0007 
Comorbidity: Suicide ideation 
      
 
No treatment vs. Psychotherapy only 
 
35.02 <.0001 <.0001  
No treatment vs. Antidepressant only 
 
0.12 0.7296 1.0000  
No treatment vs. Psychotherapy and Antidepressant 
 
0.22 0.6397 1.0000  
Psychotherapy only vs. Antidepressant only 
 
43.68 <.0001 <.0001  
Psychotherapy only vs. Psychotherapy and Antidepressant 
 
79.14 <.0001 <.0001  
Antidepressant only vs. Psychotherapy and Antidepressant 
 
0.00 0.9626 1.0000 
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Appendix Table B.2. Likelihood of using any treatment for depression vs. no 
treatment     
Adjusted OR 95% CI 
Parental depression 
   
 
Yes 
 
1.13* (1.05, 1.21)  
No 
 
Reference 
Number of depressed children in the family 
   
 
1 child 
 
Reference  
More than 1 child 0.48* (0.41, 0.55)       
Age group 
    
 
3 to 5 years 0.84 (0.68, 1.04)  
6 to 11 years 0.91 (0.83, 1.00)  
12 to 14 years 0.98 (0.90, 1.08)  
15 to 17 years Reference 
Gender 
    
 
Male 
 
Reference  
Female 
 
1.01 (0.93, 1.08) 
Comorbidity 
    
 
ADHD (Ref: no ADHD) 0.98 (0.87, 1.10)  
PTSD (ref: no PTSD) 0.75* (0.58, 0.97)  
Anxiety disorders (Ref: no anxiety disorders) 0.94 (0.85, 1.04)  
Suicide ideation (ref: no suicide ideation) 0.76 (0.58, 1.00)       
Insurance plan and Provider type 
   
 
PPO Primary care provider Reference   
Mental health provider 1.01 (0.87, 1.17)   
Other provider 0.60* (0.51, 0.72)  
HMO Primary care provider Reference   
Mental health provider 1.36* (1.05, 1.77)   
Other provider 1.27 (0.91, 1.76)  
CDHP Primary care provider Reference   
Mental health provider 1.00 (0.63, 1.57)   
Other provider 0.82 (0.45, 1.50)  
HDHP Primary care provider Reference   
Mental health provider 1.18 (0.76, 1.82)   
Other provider 0.81 (0.44, 1.48)       
Region 
    
 
Northeast 
 
Reference  
Midwest 
 
1.20* (1.09, 1.33)  
South 
 
1.26* (1.14, 1.40)  
West  
 
1.07 (0.96, 1.20) 
Note: *P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from 
logistic regression models. c-statistic: 0.569, Hosmer-Lemeshow: 0.1457. 
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Appendix Table B.3a. Likelihood of using specific treatment for depression 
(psychotherapy) vs. no treatment    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  0.80* (0.74, 0.86) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.59* (0.51, 0.69) 
Age group  
   
 3 to 5 years 1.67* (1.35, 2.07) 
 6 to 11 years 1.20* (1.08, 1.33) 
 12 to 14 years 1.00 (0.91, 1.10) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  0.93 (0.86, 1.01) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 0.85* (0.75, 0.96) 
 PTSD (ref: no PTSD) 0.49* (0.37, 0.66) 
 Anxiety disorders (Ref: no anxiety disorders) 0.60* (0.53, 0.67) 
 Suicide ideation (ref: no suicide ideation) 0.49* (0.35, 0.67) 
    
   
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 0.94 (0.80, 1.09) 
  Other provider 0.52* (0.43, 0.63) 
 HMO Primary care provider Reference 
  Mental health provider 1.05 (0.80, 1.40) 
  Other provider 0.98 (0.69, 1.39) 
 CDHP Primary care provider Reference 
  Mental health provider 0.79 (0.49, 1.28) 
  Other provider 0.57 (0.30, 1.09) 
 HDHP Primary care provider Reference 
  Mental health provider 1.08 (0.68, 1.72) 
  Other provider 0.70 (0.36, 1.35) 
Region   
   
 Northeast Reference 
 Midwest 1.05 (0.94, 1.17) 
 South  1.03 (0.93, 1.15) 
 West   1.03 (0.92, 1.15) 
Note:  
*P-value < 0.05. Adjusted odds ratios were calculated based on the parameter estimates from logistic 
regression models. c-statistic: 0.590, Hosmer-Lemeshow: 0.1696
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Appendix Table B.3b. Likelihood of using specific treatment for depression 
(pharmacotherapy) vs. no treatment    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.41* (1.28, 1.56) 
 No  Reference       
Number of depressed children in the family 
 1 child  Reference 
 More than 1 child 0.48* (0.38, 0.60) 
Age group  
   
 3 to 5 years 0.26* (0.18, 0.39) 
 6 to 11 years 0.63* (0.55, 0.72) 
 12 to 14 years 0.88* (0.79, 0.99) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  0.95 (0.86, 1.06) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.20* (1.03, 1.40) 
 PTSD (ref: no PTSD) 1.24 (0.90, 1.71) 
 Anxiety disorders (Ref: no anxiety disorders) 1.50* (1.32, 1.71) 
 Suicide ideation (ref: no suicide ideation) 0.97 (0.68, 1.38) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 0.96 (0.79, 1.16) 
  Other provider 0.66* (0.52, 0.83) 
 HMO Primary care provider Reference 
  Mental health provider 1.82* (1.22, 2.71) 
  Other provider 1.79* (1.11, 2.89) 
 CDHP Primary care provider Reference 
  Mental health provider 1.72 (0.87, 3.40) 
  Other provider 1.34 (0.56, 3.18) 
 HDHP Primary care provider Reference 
  Mental health provider 1.37 (0.73, 2.58) 
  Other provider 1.38 (0.61, 3.11) 
Region  
    
 Northeast Reference 
 Midwest 1.21* (1.06, 1.40) 
 South  1.64* (1.42, 1.88) 
 West   1.19* (1.02, 1.38) 
Note: *P-value < 0.05. 
Adjusted odds ratios were calculated based on the parameter estimates from logistic regression 
models. 
c-statistic: 0.620, Hosmer-Lemeshow: 0.3287. 
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Appendix Table B.3c. Likelihood of using specific treatment for depression 
(combination treatment) vs. no treatment    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.55* (1.43, 1.68) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.35* (0.29, 0.41) 
Age group  
   
 3 to 5 years 0.19* (0.14, 0.26) 
 6 to 11 years 0.70* (0.63, 0.78) 
 12 to 14 years 0.99 (0.90, 1.09) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  1.15* (1.06, 1.25) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.09 (0.96, 1.24) 
 PTSD (ref: no PTSD) 0.93 (0.71, 1.22) 
 Anxiety disorders (Ref: no anxiety disorders) 1.25* (1.12, 1.39) 
 Suicide ideation (ref: no suicide ideation) 1.01 (0.75, 1.34) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 1.13 (0.96, 1.33) 
  Other provider 0.69* (0.57, 0.83) 
 HMO Primary care provider Reference 
  Mental health provider 1.80* (1.34, 2.43) 
  Other provider 1.70* (1.18, 2.45) 
 CDHP Primary care provider Reference 
  Mental health provider 1.18 (0.72, 1.96) 
  Other provider 1.15 (0.60, 2.21) 
 HDHP Primary care provider Reference 
  Mental health provider 1.18 (0.73, 1.91) 
  Other provider 0.69 (0.35, 1.34) 
Region   
   
 Northeast Reference 
 Midwest 1.43* (1.28, 1.59) 
 South  1.51* (1.35, 1.69) 
 West   1.10 (0.98, 1.25) 
Note: *P-value < 0.05. 
Adjusted odds ratios were calculated based on the parameter estimates from logistic regression 
models. 
c-statistic: 0.620, Hosmer-Lemeshow: 0.7118. 
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Appendix Table B.4a. Likelihood of using pharmacotherapy vs. psychotherapy    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.82* (1.68, 1.96) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.77* (0.63, 0.94) 
Age group  
   
 3 to 5 years 0.15* (0.11, 0.21) 
 6 to 11 years 0.52* (0.47, 0.57) 
 12 to 14 years 0.87* (0.80, 0.96) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  1.03 (0.95, 1.11) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.36* (1.21, 1.54) 
 PTSD (ref: no PTSD) 2.46* (1.87, 3.24) 
 Anxiety disorders (Ref: no anxiety disorders) 2.59* (2.34, 2.86) 
 Suicide ideation (ref: no suicide ideation) 2.08* (1.52, 2.84) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 1.02 (0.88, 1.18) 
  Other provider 1.29* (1.06, 1.56) 
 HMO Primary care provider Reference 
  Mental health provider 1.77* (1.26, 2.48) 
  Other provider 1.91* (1.29, 2.84) 
 CDHP Primary care provider Reference 
  Mental health provider 2.24* (1.29, 3.88) 
  Other provider 2.23* (1.10, 4.53) 
 HDHP Primary care provider Reference 
  Mental health provider 1.40 (0.84, 2.33) 
  Other provider 2.75* (1.40, 5.38) 
Region   
   
 Northeast Reference 
 Midwest 1.17* (1.05, 1.32) 
 South  1.64* (1.46, 1.83) 
 West   1.16* (1.03, 1.31) 
Note:  
*P-value < 0.05. 
Adjusted odds ratios were calculated based on the parameter estimates from logistic regression 
models. 
c-statistic: 0.670, Hosmer-Lemeshow: 0.6450. 
 72 
Appendix Table B.4b. Likelihood of using combination treatment vs. psychotherapy    
Adjusted OR 95% CI 
Parental depression 
   
 Yes  1.98* (1.88, 2.08) 
 No  Reference 
Number of depressed children in the family 
 
 1 child  Reference 
 More than 1 child 0.56* (0.48, 0.64) 
Age group  
   
 3 to 5 years 0.11* (0.09, 0.14) 
 6 to 11 years 0.57* (0.53, 0.61) 
 12 to 14 years 0.99 (0.93, 1.05) 
 15 to 17 years Reference 
Gender   
   
 Male  Reference 
 Female  1.24* (1.18, 1.30) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 1.27* (1.17, 1.38) 
 PTSD (ref: no PTSD) 1.90* (1.53, 2.36) 
 Anxiety disorders (Ref: no anxiety disorders) 2.16* (2.01, 2.33) 
 Suicide ideation (ref: no suicide ideation) 2.25* (1.79, 2.83) 
Insurance plan and Provider type 
  
 PPO Primary care provider Reference 
  Mental health provider 1.23* (1.11, 1.36) 
  Other provider 1.38* (1.21, 1.57) 
 HMO Primary care provider Reference 
  Mental health provider 1.69* (1.38, 2.08) 
  Other provider 1.76* (1.37, 2.25) 
 CDHP Primary care provider Reference 
  Mental health provider 1.43* (1.06, 1.95) 
  Other provider 1.87* (1.23, 2.84) 
 HDHP Primary care provider Reference 
  Mental health provider 1.12 (0.82, 1.54) 
  Other provider 1.22 (0.74, 2.00) 
Region   
   
 Northeast Reference 
 Midwest 1.38* (1.28, 1.48) 
 South  1.49* (1.39, 1.61) 
 West   1.07 (0.99, 1.16) 
Note:  
*P-value < 0.05. 
Adjusted odds ratios were calculated based on the parameter estimates from logistic regression 
models. 
c-statistic: 0.670, Hosmer-Lemeshow: 0.0251. 
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Appendix Table B.4c. Likelihood of using combination treatment vs. 
pharmacotherapy    
Adjusted OR 95% CI 
Parental depression  
   
 Yes  1.09* (1.01, 1.17) 
 No  Reference 
Number of depressed children in the family 
  
 1 child  Reference 
 More than 1 child  0.74* (0.59, 0.92) 
Age group  
   
 3 to 5 years  0.81 (0.55, 1.19) 
 6 to 11 years  1.12* (1.01, 1.25) 
 12 to 14 years  1.13* (1.04, 1.24) 
 15 to 17 years  Reference 
Gender  
   
 Male  Reference 
 Female  1.20* (1.11, 1.29) 
Comorbidity  
   
 ADHD (Ref: no ADHD) 0.94 (0.84, 1.05) 
 PTSD (ref: no PTSD) 0.74* (0.58, 0.94) 
 Anxiety disorders (Ref: no anxiety disorders) 0.82* (0.75, 0.90) 
 Suicide ideation (ref: no suicide ideation) 1.00 (0.77, 1.30) 
Insurance plan and Provider type 
   
 PPO Primary care provider Reference 
  Mental health provider 1.21* (1.04, 1.41) 
  Other provider 1.03 (0.85, 1.25) 
 HMO Primary care provider Reference 
  Mental health provider 0.96 (0.68, 1.36) 
  Other provider 0.92 (0.62, 1.37) 
 CDHP Primary care provider Reference 
  Mental health provider 0.62 (0.36, 1.09) 
  Other provider 0.83 (0.41, 1.68) 
 HDHP Primary care provider Reference 
  Mental health provider 0.80 (0.48, 1.34) 
  Other provider 0.45* (0.23, 0.88) 
Region  
   
 Northeast  Reference 
 Midwest  1.15* (1.03, 1.29) 
 South  0.91 (0.82, 1.02) 
 West   0.92 (0.82, 1.04) 
Note: *P-value < 0.05. 
Adjusted odds ratios were calculated based on the parameter estimates from logistic regression 
models. 
c-statistic: 0.560, Hosmer-Lemeshow: 0.7010 
  
7
4
 
Appendix Table B.5. Association of the interaction between insurance plan and provider type with depression 
treatment  
   
Psychotherapy only vs. no 
treatment 
Pharmacotherapy only vs. no 
treatment 
Combination treatment vs. no 
treatment 
  aOR 95% CI aOR 95% CI aOR 95% CI 
Insurance plan and Provider type 
       
Primary 
care 
provider 
PPO Reference Reference Reference 
HMO 0.86 (0.64, 1.15) 0.60* (0.40, 0.91) 0.74 (0.54, 1.01) 
CDHP 1.22 (0.76, 1.96) 0.67 (0.34, 1.31) 1.01 (0.61, 1.67) 
HDHP 0.82 (0.53, 1.28) 0.75 (0.41, 1.37) 0.88 (0.55, 1.39) 
Mental 
health 
provider 
PPO Reference Reference Reference 
HMO 0.97 (0.86, 1.09) 1.14 (0.98, 1.32) 1.18* (1.05, 1.33) 
CDHP 1.02 (0.87, 1.21) 1.19 (0.97, 1.46) 1.06 (0.89, 1.26) 
HDHP 0.95 (0.78, 1.17) 1.07 (0.83, 1.38) 0.92 (0.74, 1.13) 
Other 
provider 
PPO Reference Reference Reference 
HMO 1.62* (1.24, 2.11) 1.64* (1.18, 2.28) 1.83* (1.40, 2.40) 
CDHP 1.34 (0.84, 2.14) 1.35 (0.75, 2.44) 1.69* (1.07, 2.70) 
HDHP 1.11 (0.66, 1.86) 1.57 (0.87, 2.83) 0.88 (0.52, 1.49) 
 
Note: *P-value < 0.05. aOR (adjusted odds ratios) were calculated from the respective logistic regression models listed in Appendix Tables B.3a 
– B.4c by changing the reference level of the main effects and interaction of insurance plan and provider types. 
 
 
 
 
 
 
 
 
 
  
7
5
 
Appendix Table B.5. Association of the interaction between insurance plan and provider type with depression 
treatment (Cont’d) 
    
Pharmacotherapy only vs. 
psychotherapy only 
Combination treatment vs. 
psychotherapy only 
Combination therapy vs. 
pharmacotherapy only 
  aOR 95% CI aOR 95% CI aOR 95% CI 
Insurance plan and Provider type 
       
Primary 
care 
provider 
PPO Reference Reference Reference 
HMO 0.72 (0.51, 1.02) 0.92 (0.74, 1.13) 1.26 (0.88, 1.81) 
CDHP 0.55* (0.32, 0.95) 0.88 (0.65, 1.20) 1.67 (0.96, 2.91) 
HDHP 0.82 (0.50, 1.34) 1.01 (0.75, 1.37) 1.34 (0.81, 2.20) 
Mental 
health 
provider 
PPO Reference Reference Reference 
HMO 1.25* (1.12, 1.39) 1.26* (1.17, 1.36) 1.00 (0.90, 1.12) 
CDHP 1.20* (1.03, 1.40) 1.03 (0.93, 1.15) 0.86 (0.74, 1.00) 
HDHP 1.12 (0.92, 1.36) 0.93 (0.81, 1.06) 0.89 (0.73, 1.08) 
Other 
provider 
PPO Reference Reference Reference 
HMO 1.07 (0.82, 1.39) 1.17 (0.98, 1.40) 1.12 (0.86, 1.45) 
CDHP 0.95 (0.58, 1.54) 1.20 (0.87, 1.65) 1.34 (0.85, 2.14) 
HDHP 1.74* (1.06, 2.84) 0.90 (0.59, 1.36) 0.58* (0.35, 0.95) 
 
Note: *P-value < 0.05. aOR (adjusted odds ratios) were calculated from the respective logistic regression models listed in Appendix Tables B.3a 
– B.4c by changing the reference level of the main effects and interaction of insurance plan and provider types. 
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